Skip to main content
eLife logoLink to eLife
. 2020 Jan 9;9:e52158. doi: 10.7554/eLife.52158

A processive rotary mechanism couples substrate unfolding and proteolysis in the ClpXP degradation machinery

Zev A Ripstein 1,2,†,, Siavash Vahidi 1,2,3,4,†,, Walid A Houry 1,4, John L Rubinstein 1,2,5,, Lewis E Kay 1,2,3,4,
Editors: Axel T Brunger6, John Kuriyan7
PMCID: PMC7112952  PMID: 31916936

Abstract

The ClpXP degradation machine consists of a hexameric AAA+ unfoldase (ClpX) and a pair of heptameric serine protease rings (ClpP) that unfold, translocate, and subsequently degrade client proteins. ClpXP is an important target for drug development against infectious diseases. Although structures are available for isolated ClpX and ClpP rings, it remains unknown how symmetry mismatched ClpX and ClpP work in tandem for processive substrate translocation into the ClpP proteolytic chamber. Here, we present cryo-EM structures of the substrate-bound ClpXP complex from Neisseria meningitidis at 2.3 to 3.3 Å resolution. The structures allow development of a model in which the sequential hydrolysis of ATP is coupled to motions of ClpX loops that lead to directional substrate translocation and ClpX rotation relative to ClpP. Our data add to the growing body of evidence that AAA+ molecular machines generate translocating forces by a common mechanism.

Research organism: Other

Introduction

Protein degradation plays a central role in cellular physiology, regulating the timing of cell division, controlling stress responses, and ensuring the timely removal of damaged or aberrantly folded proteins (Olivares et al., 2016; Goldberg, 2003). The ClpXP system is central to protein degradation in bacteria and in mitochondria, where it has recently emerged as a therapeutic target against malignancies (Ishizawa et al., 2019), and is a key regulator of cellular homeostasis, pathogenesis, and intracellular parasitism (Frees et al., 2014; Pickart and Cohen, 2004; Bhandari et al., 2018). It also serves as a model for understanding the structure and function of other ATP-dependant proteolytic systems. The ClpXP holoenzyme is composed of a hexameric AAA+ (ATPases Associated with diverse cellular Activities) unfoldase (ClpX) and a tetradecameric serine protease consisting of two heptameric rings (ClpP). Together, the ClpXP complex acts to unfold and degrade protein substrates (Figure 1A; Baker and Sauer, 2012). ClpXP function is critical in many bacteria, and consequently small molecules that disrupt either the protease (e.g. β-lactones [Böttcher and Sieber, 2008], phenyl esters (Hackl et al., 2015; Lakemeyer et al., 2019) or the AAA+ unfoldase (e.g. ecumicin (Gao et al., 2015), lassomycin (Gavrish et al., 2014), rufomycin (Choules et al., 2019), dihydrothiazepines (Fetzer et al., 2017), or mimic the interaction between the two (e.g. acyldepsipeptides [ADEPs] (Kirstein et al., 2009; Gersch et al., 2015; Wong et al., 2018) can kill cells, establishing ClpXP as a target for novel therapeutics against a range of different infectious diseases and cancers (Culp and Wright, 2017; Malik and Brötz-Oesterhelt, 2017; Raju et al., 2012; Goard and Schimmer, 2014; Wong and Houry, 2019).

Figure 1. Functional and structural characterization of ClpXP from N. meningitidis.

(A) Schematic representation of the ClpXP degradation machinery. The overall positions of the substrate (orange), ClpX unfoldase (green), and the ClpP protease (blue) are shown; (B) GFP-SsrA degradation by ClpXP is ATP-dependent. The degradation rate of GFP-SsrA is monitored by measuring loss of fluorescence. The components (ClpX, ClpP, ATP) included for each measurement are denoted on the plot. All measurements included GFP-SsrA and were performed in triplicate on WT ClpXP; (C) ClpXP complex formation monitored by size exclusion chromatography (SEC). SEC profiles of isolated ClpP (blue trace) and ClpX (green trace) are consistent with their expected molecular weights. SEC profile of a 2:1 ClpX6:ClpP14 mixture (red trace) incubated for 10 min in the presence of MgATP shows the formation of doubly- and singly-capped ClpXP complexes. The running buffer for all traces contained 2 mM MgATP. SDS-PAGE gel of SEC fractions (fractions within the region delineated by black bracket) shows that they contain both ClpP and ClpX; (D) Overall architecture of the ClpXP complex as established by cryo-EM. The ClpP double ring component is shown in dark blue, with the exception of a pair of opposing protomers shown in light blue shade to delineate the IGF loop binding site that is located at the interface between protomers. Cutaway side (E) and top (F) views of Conformations A and B of ClpX resulting from focused classification and local refinement. The IGF loops that bind to ClpP, and the presence of substrate (orange) in the axial channel of ClpX, are highlighted. Each of the ClpX protomers is labeled. In panel (F), the engagement of the substrate (orange) with five of the six pore loops is indicated (red semi-circle).

Figure 1.

Figure 1—figure supplement 1. Sequence map of NmClpX and SEC analysis of substrate binding by NmClpXP.

Figure 1—figure supplement 1.

(A) NmClpX primary sequence domain map. Important structural and functional motifs are denoted. (B) NmClpXP binds a SsrA-tagged GFP. SEC profiles for ClpXP incubated with GFP-SsrA (top panel) and GFP-SsrA alone (bottom panel) measured using absorbance at 280 nm (black trace) and GFP fluorescence (green trace - λex:480 nm, λem:508 nm). The region used for SDS-PAGE analysis is highlighted by * (Figure 1C).

Figure 1—figure supplement 2. Cryo-EM image processing.

Figure 1—figure supplement 2.

(A) Representative cryo-EM micrograph of NmClpXP bound to GFP-SsrA. Example complexes are circled in white. (B) Representative 2D class averages of NmClpXP with GFP-SsrA. (C) Image processing workflow used to obtain final maps.

Figure 1—figure supplement 3. Cryo-EM map validation.

Figure 1—figure supplement 3.

(A to C) Fourier Shell Correlation (FSC) plots (left) and orientation distribution (right). Resolution values reported are for FSC = 0.143.

Figure 1—figure supplement 4. Examples of regions of the atomic models built into the experimental cryo-EM maps.

Figure 1—figure supplement 4.

Figure 1—figure supplement 5. Experimental density maps and models for the substrate pore-1 loop interaction interface.

Figure 1—figure supplement 5.

X-ray crystallographic studies of ClpP alone reveal a barrel-like structure with the protease rings stacked coaxially to form an enclosed degradation chamber, akin to the 20S proteasome (Förster et al., 2013; Kish-Trier and Hill, 2013), that sequesters the fourteen Ser-His-Asp catalytic triads (Wang et al., 1997; Liu et al., 2014). Early negative-stain electron microscopy showed that one or two ClpX particles can bind co-axially to ClpP, creating a continuous central channel for substrates from ClpX to the degradation chamber of ClpP (Ortega et al., 2002; Ortega et al., 2000; Kessel et al., 1995). Biochemical and X-ray crystallographic studies show that the axial entrances to the degradation chamber are gated by flexible N-terminal loops of ClpP that open upon the binding of ClpX or ADEPs, allowing substrates into the degradation chamber (Lee et al., 2010; Li et al., 2010; Effantin et al., 2010). Binding of ClpX and ClpP is mediated by loops containing an Ile/Leu-Gly-Phe motif (I/LGF loops) on ClpX that dock into hydrophobic pockets on the apical interfaces of ClpP subunit pairs (Kim et al., 2001; Joshi et al., 2004; Amor et al., 2019). N-terminal loops on ClpP also transiently interact with ClpX (Joshi et al., 2004; Gribun et al., 2005; Jennings et al., 2008). However, the precise nature of these interactions and how they allow coordination of the activities of ClpX and ClpP remains unclear.

ClpX uses energy released by ATP hydrolysis to create a pulling force that unravels folded protein domains for translocation into the degradation chamber of ClpP (Baker and Sauer, 2012). This unfolding activity relies on a series of conserved loops in ClpX. These loops include the ‘RKH’ loops that surround the ClpX entrance pore and recognize substrates for proteolysis (Martin et al., 2008a), and a pair of ‘pore loops’ in each protomer, termed pore-1 loop (GYVG in Neisseria meningitidis ClpX, NmClpX) and pore-2 loop (RDV in NmClpX) (Figure 1—figure supplement 1A) that line the axial channel of the ClpX ring (Martin et al., 2008b). Bulky aromatic and aliphatic side chains of the pore loops transmit the pulling force to the substrate, leading to its unfolding. The mechanism by which some AAA+ ATPases convert energy from ATP hydrolysis into a mechanical force that unfolds substrates was established recently (Monroe et al., 2017; Yu et al., 2018; De la Peña et al., 2018; Shin et al., 2019; Ripstein et al., 2017; Gates et al., 2017), and structures of ClpP and ClpX in isolation have been determined (Ishizawa et al., 2019; Li et al., 2016; Geiger et al., 2011; Glynn et al., 2009). However, the absence of structures showing ClpXP in the process of unfolding substrate has prevented an understanding of the conformational changes that are necessary for substrate engagement, unfolding, and translocation in this system. ClpXP must undergo hundreds of ATP hydrolysis events to unfold and degrade a single protein, likely via a process involving hydrolysis of one nucleotide at a time, but the lack of structural information for a ClpXP holoenzyme has limited understanding of how unfolding and degradation are coupled. For example, it is not clear how the symmetry mismatch (Bewley et al., 2006; Beuron et al., 1998; Majumder et al., 2019) between the pseudo-symmetric hexameric ClpX and the seven-fold symmetric ClpP affects both the binding and interaction of these two components.

Here, we present cryo-EM structures of the ClpXP holoenzyme from the gram-negative pathogen Neisseria meningitidis engaged with a protein substrate. The ClpXP portion of the structure is at 2.3 to 3.3 Å resolution, allowing construction of a nearly complete atomic model of the complex. Our findings show how ClpX grips and translocates substrates into the degradation chamber through a cycle of ATP hydrolysis events involving both concerted motions of pore loops along the substrate, as well as motions of ClpX on the apical surface of ClpP. The data lead to a model for interactions between symmetry-mismatched ClpX and ClpP that enable continuous degradation of substrates as ClpX rotates relative to ClpP.

Results

ATP-dependent binding and degradation of GFP-SsrA by ClpXP

ClpX and ClpP from N. meningitidis (Nm) were expressed separately in E. coli before purification with metal affinity chromatography and size exclusion chromatography (SEC). Degradation assays using green fluorescent protein bearing an eleven-residue SsrA tag (GFP-SsrA) (Ripstein et al., 2017) were performed to ensure that the heterologously expressed NmClpX and NmClpP proteins, when mixed, have the well-established activity of the ClpXP holoenzyme. The presence of ClpP or ClpX alone led to no loss of GFP-SsrA fluorescence relative to background bleaching in the GFP-alone control assay. ClpX, ClpP, and ATP were all necessary to degrade GFP-SsrA (Figure 1B), confirming that degradation of GFP-SsrA by ClpXP is ATP-dependent. As shown below and in previous work (Joshi et al., 2004; Hersch et al., 2005; Grimaud et al., 1998; Jones et al., 1998), the presence of MgATP is required for tight binding between ClpX and ClpP. Therefore, for further structural studies, an E185Q Walker B mutant of NmClpX (ClpX-WB) was used to slow ATP hydrolysis and prolong the lifetime of the ClpXP complex. SEC was performed to probe the oligomeric state of each component and the formation of the holoenzyme, confirming that ClpP behaves as an oligomeric species, consistent with its well-known tetradecameric architecture (Figure 1C – blue trace). ClpX-WB eluted as a hexamer in the presence of 2 mM MgATP (Figure 1C – green trace). Incubation of ClpX-WB and ClpP in the presence of MgATP resulted in a pair of higher molecular weight SEC peaks that contain both ClpX and ClpP (Figure 1C – red trace and SDS-PAGE gel insert), presumably corresponding to singly and doubly capped ClpXP complexes, showing that the N. meningitidis ClpX:ClpP complex can be readily reconstituted in vitro.

To isolate a substrate-bound holoenzyme, ClpXP was incubated with GFP-SsrA in the presence of MgATP. SEC fractions corresponding to doubly capped ClpXP bound to GFP-SsrA (Figure 1—figure supplement 1B - denoted with a *) were applied to specimen grids and vitrified for cryo-EM analysis. Visual inspection of the micrographs, as well as 2D classification of particle images, showed doubly capped complexes (Figure 1—figure supplement 2). However, 2D classification showed multiple classes where the two ClpX rings have lower density than the ClpP region, and other classes with one ClpX ring having strong density and the other having weak density. An ab initio 3D map showed ClpP along with strong density for one ClpX ring and only weak and fragmented density for the other (Figure 1—figure supplement 2C). Inspection of the map revealed that the ClpX ring is offset and tilted relative to the ClpP symmetry axis (Figure 1D, Video 1). The poor density for the second ClpX hexamer is likely due to a lack of correlation between binding offsets of the two ClpX rings that leads to incoherent averaging of one of the ClpX rings in the map. The map of the intact complex was refined to an overall resolution of 2.8 Å (Figure 1—figure supplement 2C); however, the density for the better-resolved ClpX ring remained fragmented. Further local refinement and classification in cryoSPARC (Punjani et al., 2017) improved the density for ClpX and revealed two distinct conformations, at 3.3 Å and 2.9 Å resolution (Figure 1—figure supplement 2), hereafter referred to as Conformations A and B, respectively. Focused refinement of ClpP with D7 symmetry enforced led to a map at 2.3 Å resolution (Figure 1—figure supplement 2).

Video 1. Overview of the substrate-bound ClpXP complex (Conformation B).

Download video file (20.1MB, mp4)

Overall architecture of NmClpXP

Atomic models built into the cryo-EM maps showed that in both Conformations A and B, ClpX is positioned with an offset and is tilted relative to the seven-fold symmetry axis of ClpP (Figure 1D, Video 1). Nevertheless, a continuous channel for substrate spans the ClpX and ClpP rings. ClpP is in its active extended conformation (Goodreid et al., 2016), and closely resembles a published ADEP-bound crystal structure with an all atom RMSD of 1.18 Å for the tetradecamer (pairwise comparison of the chains gives values from 1.12 to 1.22 Å with a standard deviation from the mean of 0.03 Å) (Goodreid et al., 2016). Even though the full-length constructs of ClpX included the zinc binding domains (residues 1–62), no density was found for these domains in either conformation, likely due to their flexibility.

Conformations A and B of ClpX both contained additional density along their axial channels, adjacent to the pore loops, likely from the GFP-SsrA substrate that co-eluted with ClpXP from the SEC column (Figure 1E and F - orange) (Figure 1—figure supplement 1B). As the Walker B mutant has low unfolding activity (Martin et al., 2008c), the density observed likely corresponds to the unstructured region of the degron tag. The substrate enters ClpX at an angle of ~15° relative to the ClpP symmetry axis and is gripped by five of the six ClpX protomers arranged in a right-handed spiral, akin to other AAA+ ATPases in their substrate-bound conformations (Monroe et al., 2017; Yu et al., 2018; De la Peña et al., 2018; Shin et al., 2019; Ripstein et al., 2017; Gates et al., 2017). The sixth protomer forms a disengaged ‘seam’ that bridges protomers at the beginning and end of the spiral. In the description that follows we have labeled the protomers X1 through X6 corresponding to their position in the spiral (Figure 1F), and consider the configuration in which X1 is the disengaged ‘seam’ protomer of Conformation A.

The main differences between Conformations A and B are within the protomer that adopts the bridging seam position, and where the seam is located relative to ClpP. In Conformation A, protomer X1 is disengaged from substrate and in the seam position (Figure 1F left - dark blue) while in Conformation B protomer X6 is disengaged from substrate and in the seam position (Figure 1F right - yellow). However, these two seam positions are not equivalent: in Conformation A the seam is further from the apical surface of ClpP in what we designate as the ‘upper seam’ (US) position (Figure 1D,F - dark blue), while in Conformation B, the seam is closer to ClpP in the ‘lower seam’ (LS) position (Figure 1D,F - yellow).

ClpX IGF loops

In both Conformations A and B of ClpXP, there is clear density for most of the IGF loops that extend from the ClpX ring toward the apical surface of ClpP (Figure 2A). In Conformation A, clear density is observed for only five of the six IGF loops, with weak density belonging to the IGF loop of the X6 protomer (white dotted line in Figure 2B left; Figure 2—figure supplement 1). In Conformation B, the density of the X6 IGF loop is significantly stronger than in Conformation A, so that all six of the IGF loops are accounted for (residues 264–274, Figure 2B, right; Figure 2C; Figure 2—figure supplement 1), with the loops binding six of the seven pockets on ClpP. In both Conformations A and B, the empty ClpP-binding pocket is located between the X5 and X6 protomers of ClpX (Figure 2B). The lack of density for the IGF loop belonging to protomer X6 in Conformation A (Figure 2—figure supplement 1) is likely due to conformational flexibility and sub-stoichiometric binding of this IGF loop into the ClpP-binding pocket.

Figure 2. The interaction interface between ClpX and ClpP.

Protomer X1 occupies the US position in Conformation A and protomer X6 the LS position in Conformation B. (A) Cutaway density map of the overall architecture of the ClpXP interaction interface. (B) Models for the ClpP apical surface and the ClpX IGF loops (residues 265–275). The empty IGF-binding pocket (dotted oval) resides clockwise to the X5 protomer in both conformations. In Conformation A, an IGF loop was not built into the map for protomer X6 due to weak loop density (yellow dotted line). (C) Model in map fit for an IGF loop (grey), surrounded by regions of ClpP comprising the IGF binding site (blue). (D) Interaction of the ClpP N-terminal gates with ClpX. The X2 protomer moves away from the gates, while the X5 protomer directly contacts the gate of the ClpP protomer to which its IGF loop is bound, shown in (E). Inset shows the details of this interaction, with model in map fit for the ClpP β-hairpin. (F) Positions of ClpX protomers relative to ClpP. Images were generated by fitting all ClpP protomers to a common protomer and displaying the corresponding ClpX protomer. In both conformations, ClpX adopts a spiral arrangement relative to ClpP (dotted red line). In Conformation A, the X2 protomer is located at the top of the spiral, while in Conformation B the X1 protomer occupies the top position, ~7 Å higher than its position in Conformation A. The ClpX protomers rotate and translate relative to ClpP; protomers X2 and X3 sit nearly atop their ClpP protomers, while X4 and especially X5 show large deviations from this position (vertical lines), with X5 sitting overtop the ClpP axial pore. (G) View down the channel formed by the N-terminal ClpP β-hairpins (left); density and models for the most flexible and rigid β-hairpins (center and right, respectively).

Figure 2.

Figure 2—figure supplement 1. IGF loop flexibility.

Figure 2—figure supplement 1.

(A and B) Large domains of ClpX were aligned and models for the IGF loops are shown. (C and D) Unsharpened density map for Conformations A and B looking at protomer X6.
Figure 2—figure supplement 2. The ClpP apical loops extend upwards from the ring surface.

Figure 2—figure supplement 2.

(A) Unsharpened density map of the ClpP N-terminal β-hairpins when bound to ClpX. (B) Cryo-EM map of apo ClpP from N. meningitidis showing that the apical loops no longer extend ‘up’. (C) ClpX-bound and apo forms of ClpP overlaid. There is no noticeable density for the turn of the ClpP N-terminal β-hairpin in the apo form, and the β-hairpins point inwards, constricting the axial pore of ClpP. (D) Fourier Shell Correlation (FSC) plot for Apo-NmClpP. (E) Closeup view of the N-terminal β-hairpins when bound to ClpX. (F) Density map of the β-hairpins in the ClpXP complex, colored by local resolution.

All six IGF loops in ClpX adopt different configurations in Conformations A and B (Figure 2—figure supplement 1). The ClpX residues immediately following where the IGF loops contact ClpP (residues 275–280) show weak or no density, likely indicating flexibility. This property allows the IGF loops to accommodate movement of the ClpX protomers relative to ClpP (Figure 2D–F), analogous to a set of springs. For instance, in Conformation A the X1 protomer is closer to the ClpP surface than in Conformation B and its IGF loop is thus compact in this state. In contrast, in Conformation B the loop is fully extended, allowing the X1 protomer to reach upwards toward the top of the spiral to engage the substrate (Figure 2F; Figure 2—figure supplement 1). In this way, the flexibility of the IGF loops accommodates the spiral arrangement of ClpX necessary to bind and unfold substrate, while maintaining contact with the planar ring of ClpP. Additionally, the IGF loops allow the X2 protomer to move laterally away from the ClpP pore while the X4 and X5 protomers move toward it to form a structure in which the ClpP and ClpX rings are displaced with respect to each other (Figure 2D-red arrow; Figure 2E).

ClpP N-terminal gates

Degradation assays (Effantin et al., 2010; Gribun et al., 2005; Martin et al., 2007; Ortega et al., 2004; Singh et al., 2000) show that ClpX allows substrate access to the degradation chamber of ClpP, suggesting that ClpX binding opens the N-terminal gates of ClpP. Indeed, in both Conformations A and B the gates are in the ‘up’ state, forming ordered β-hairpins (Figure 2G; Figure 2—figure supplement 2). These β-hairpins closely resemble the conformation seen in the ADEP-bound structures of NmClpP (Goodreid et al., 2016) and are notably different from the disordered conformations observed in NmClpP when it is not bound to either ClpX or ADEP (Figure 2—figure supplement 2BMabanglo et al., 2019). By forming ordered gates, ClpX binding creates a wide entrance pore with a diameter of ~23 Å for substrates to pass through into the ClpP degradation chamber (Figure 2G, left; Figure 2—figure supplement 2). While it has long been suspected that the activating mechanism of ADEPs involves a disorder-to-order transition of these gates (Li et al., 2010), this observation provides direct evidence that ClpX binding has the same effect.

In both Conformations A and B, the rigidification of the ClpP N-terminal gates varies substantially between protomers. At one extreme, the N-terminal residues of the ClpP protomer that is not bound to an IGF loop have the weakest density, appearing to possess the most flexibility at the top of the β-hairpin (Figure 2G center; Figure 2—figure supplement 2E). In contrast, the N-terminal residues of the ClpP protomer proximal to the X5 ClpX protomer, are held rigidly through contacts with the ATPase (Figure 2G right). This interaction is mediated by a pair of α-helices from protomer X5 (residues 254–262 and 291–296) adjacent to the IGF loop, and by another X5 α-helix that precedes the pore-2 loop (residues 186–192). The three α-helices stabilize the β-hairpin structure of the ClpP N-terminal residues by interacting with Arg17 at the top of the hairpin (Figure 2E inset). These interactions are unique for the X5 protomer due to the lateral displacement of the ClpX ring relative to the axial pore of ClpP (Figure 2A), with the X2 protomer shifted furthest from the pore while the X5 protomer is pulled overtop of the pore (Figure 2D and F). Even without interacting directly with ClpX, the remaining five ClpP protomers have nearly rigid N-terminal gates, with reduced density only for residues located in the turn of the β-hairpin that likely reflects increased flexibility in this region (Figure 2—figure supplement 2F). Gate rigidification therefore appears to be mediated by an allosteric effect when IGF loops engage their respective ClpP binding pockets, akin to the effect observed upon ADEP binding (Gersch et al., 2015; Li et al., 2010). In the ClpXP complex with substrate bound, only a single ClpX protomer (X5) interacts directly with a single ClpP gate at any given time. The mechanism of substrate translocation described below involves movement of the ClpX ring on the apical surface of ClpP, with each ClpX protomer forming contacts with a ClpP gate as translocation proceeds.

Substrate engagement by ClpX

ClpX fits neatly into the emerging consensus for how AAA+ unfoldases engage substrate (Monroe et al., 2017; Yu et al., 2018; De la Peña et al., 2018; Shin et al., 2019; Ripstein et al., 2017). In both Conformations A and B, five of the six pore-1 loops of ClpX interact tightly with the substrate backbone, with Tyr153 forming the majority of the interface (Figure 3A and B). These protomers generate a right-handed spiral that wraps around an 8 to 10 residue stretch of the substrate along the central channel of ClpX (Figure 3C and D). In Conformation A, the X1 pore-1 loop in the US orientation is disengaged, with the X2 protomer at the top of the spiral. As the spiral continues downwards, protomers X3, X4, and X5 make contacts with the substrate. The spiral terminates with the X6 pore-1 loop that is engaged with the substrate closest to the ClpP apical surface (Figure 3C). In Conformation B, the X6 pore-1 loop is disengaged (LS orientation), while the X1 pore-1 loop engages a new section of substrate (Figure 3D) and the X5 protomer is now located closest to the ClpP surface. When transitioning between substrate-engaged and disengaged states, the X6 pore-1 loop undergoes a large conformational change (Figure 3E). As it disengages the substrate the ‘lasso’ fold (Figure 3E, left) that allows Tyr153 and Val154 of pore-1 to point toward the substrate is replaced by a short α-helix immediately following the GYVG motif of the loop.

Figure 3. Substrate engagement by the ClpX pore loops.

(A and B) Pore-1 loop residues grip the substrate, as observed in this view looking down the axial channel. The substrate is modeled as poly-Ala. (A) In Conformation A, the X1 protomer is disengaged from the substrate in the US position (red arrow) and shows noticeable flexibility in its pore-1 loop. (B) In Conformation B, the X1 protomer contacts the substrate but the X6 protomer has disengaged into the LS position (red arrows). (C and D) Model of substrate and interacting residues, along with schematic, viewed perpendicular to the axial channel. (C) In Conformation A, only the Tyr153 residue of the pore-1 loop makes significant contacts with the substrate; the five protomers (X2, X3, X4, X5, X6) form a downward spiral surrounding the backbone of the substrate chain, extending to the apical surface of ClpP. (D) In Conformation B, in addition to the five Tyr153 residues from the five gripping protomers (X1, X2, X3, X4, X5), more contacts are formed: Ser197 and Ile198 from the pore-2 loop of the X1 protomer and His230 from the RKH loop of the X5 protomer. (E) Substrate-induced conformational changes of the X6 pore-1 loop upon releasing client. When the X6 protomer is substrate engaged its pore-1 loop forms a lasso like conformation, with Tyr153 and Val154 both pointing toward the axial channel (left). When disengaged, a part of the pore-1 loop becomes an α-helix, with Val154 and Tyr153 no longer pointing outwards (right). (F) Architecture of the additional contacts made by the pore-2 and RKH loops from the X1 and X5 protomers, respectively.

Figure 3.

Figure 3—figure supplement 1. RKH loop positions.

Figure 3—figure supplement 1.

(A and B) Unsharpened maps for both conformations A and B of ClpX are shown, with RKH loops highlighted in color (coloring done by a radius of 10 Å around residues 220–240).

Interestingly, the X1 and X5 protomers make additional contacts with the substrate in Conformation B. Whereas all of the pore-2 loops from the other five protomers are radially removed and disengaged from the substrate, the X1 protomer extends its pore-2 loop residues Ile198 and Thr199 to engage the substrate at a position three or four residues down the substrate chain from where its pore-1 loop binds (Figure 3D and F). The RKH loops, located at the top of the ClpX ring (Figure 3—figure supplement 1), are conserved motifs among the ClpX family of AAA+ unfoldases and are known to contribute to substrate recognition (Martin et al., 2007; Farrell et al., 2007; Siddiqui et al., 2004). In Conformation B, only the RKH loop of X5 directly engages substrate, with its His230 residue interacting at a position three or four residues up the substrate chain from where its pore-1 loop binds (Figure 3D and F). In order to contact substrate at this position the RKH loop of the X5 protomer rearranges to point toward ClpP (Figure 3F), in contrast to the other RKH loops that point away from the axial channel of ClpX (Figure 3—figure supplement 1). These five RKH loops are located away from the substrate, and have weaker density in the maps, likely indicating flexibility.

Nucleotide state and cycling in ClpX

The cryo-EM maps allowed unambiguous identification of the nucleotide bound to each ClpX protomer. In Conformation A, there is strong density for ATP and a magnesium cofactor in protomers X2, X3, X4, and X5, while the X1 and X6 protomers are ADP loaded, with no density for either the γ-phosphate or magnesium (Figure 4A and C). As in both the classic and HCLR clades of AAA+ ATPases (Monroe et al., 2017; Yu et al., 2018; De la Peña et al., 2018; Shin et al., 2019; Ripstein et al., 2017), the orientation between the large and the small AAA+ domains of ClpX changes considerably depending on the nucleotide state. In Conformation A, both the X1 and X6 protomers adopt conformations that allow the X1 protomer to move away from the pore in the US position (Figure 4—figure supplement 1) and there is reduced surface area buried between X1 and its neighboring protomers X2 and X6. In agreement with this finding, the local resolution in the cryo-EM maps (Figure 4—figure supplement 2) suggests that the X1 protomer in the US position is significantly more flexible than the other protomers. In Conformation B, only the X6 protomer is ADP-bound. The X1, X2, X3, X4, and X5 protomers are ATP-bound with clear density for the γ-phosphate and the magnesium cofactor (Figure 4B and D). Interestingly, the X5 protomer adopts a unique orientation between its large domain and small domain compared to the other ATP-bound protomers in order to accommodate the translation of the X6 protomer away from the substrate translocation channel into the LS position (Figure 4B orange box; Figure 4—figure supplement 1).

Figure 4. Nucleotide occupancy and interactions with ClpX.

(A and B) Model of ClpX in conformations A and B, looking into the ClpX pore. Nucleotides are shown and color-coded, with ATP red and ADP purple, and bind between the large and small domains (boxed). Inset shows a schematic of the protomer positions and nucleotide occupancies. Conformation A has two bound ADP, in the X1 (dark blue, US in Conformation A in this representation) and X6 (yellow, LS in Conformation B in this representation) protomers, with the X1 protomer disengaged from the substrate and away from the axial pore (US position). In Conformation B only a single ADP is bound, protomer X1 is reengaged with substrate and X6 has disengaged. (C) Nucleotide-binding sites of Conformation A, with key interacting residues shown along with the experimental density maps corresponding to bound nucleotide. In the ADP-bound sites, both the arginine finger (R306) and the sensor-II arginine (R369) have moved away, while in the ATP bound sites they form close contacts with the β and γ-phosphates. (D) Nucleotide binding in Conformation B. As in Conformation A, R306 and R369 have moved away from the ADP, while in the X5 protomer only the arginine finger has moved away, while the sensor-II transitions closer to the γ-phosphate.

Figure 4.

Figure 4—figure supplement 1. Relative orientation between large and small domains of ClpX.

Figure 4—figure supplement 1.

(A and B) Residues 308–343 are shown. Note that protomers X1 and X6 in Conformations A and B, respectively, are displaced from substrate. These show among the largest differences in domain orientations.
Figure 4—figure supplement 2. Local resolution maps of ClpX.

Figure 4—figure supplement 2.

(A and B) Density maps colored by local resolution for Conformations A and B. In Conformation A the US protomer is highlighted with a dashed line.
Figure 4—figure supplement 3. ATP-binding pocket densities.

Figure 4—figure supplement 3.

Experimental density maps and models are shown for the ATP-binding pockets of all protomers. Two numerical thresholds are shown to highlight differences in density.

In Conformation A, the β- and γ-phosphates of the bound ATP are stabilized by interactions with the sensor-II arginine (Arg369) of the same subunit and the arginine finger (Arg306) from the adjacent clockwise protomer (Figure 4C). In the ADP-bound sites of the X1 and X6 protomers, both arginines have moved away, allowing for a more open nucleotide-binding pocket (Figure 4C). In Conformation B, both the sensor-II arginine and the arginine finger contact the β and γ-phosphates in only four of the five ATP-bound protomers (X1, X2, X3, and X4) (Figure 4D). In the X5 protomer (at the bottom of the spiral), the adjacent X6 protomer and its arginine finger have pivoted away from the nucleotide into the LS position, allowing the sensor-II arginine to move closer to the γ-phosphate of the bound nucleotide. While there is clear density for the γ-phosphate, the resolution of our experimental map was not sufficient to differentiate between ATP and a long-lived post-hydrolysis ADP/Pi state. Notably, this key sensor II-priming motif in the nucleotide site adjacent to an ADP bound site has also been reported for the Lon protease bound to substrate (Shin et al., 2019), a close relative in the HCLR clade of AAA+ proteins.

Discussion

In this study, we used cryo-EM to build atomic models of a ClpXP complex bound to a SsrA-tagged GFP substrate. Structures of a variety of different AAA+ rings with substrates have emerged in the past several years (Monroe et al., 2017; Yu et al., 2018; De la Peña et al., 2018; Shin et al., 2019; Ripstein et al., 2017), providing a description of how these ATP-dependent molecular machines unfold substrates. In addition, methyl-TROSY NMR studies of a VAT-substrate complex provided atomic-level insights into structural changes associated with the substrate as it is pulled into the lumen of the unfoldase (Augustyniak and Kay, 2018). Nevertheless, a detailed understanding of how a pair of symmetry mismatched ClpP/ClpX rings can work in tandem to unfold, translocate, and subsequently degrade substrate in a processive manner has remained elusive. Our structural data suggest a translocation mechanism that can be explained in terms of a pair of conformers, denoted as Conformations A and B here, that represent two steps along the substrate translocation pathway (Figure 5A). To aid in the following discussion, we have color-coded the ClpX protomers and refer to them with their X1 - X6 labels. As we will discuss, each of these protomers will cycle between all six protomer positions along the spiral, including, among others, a state primed to hydrolyze ATP (denoted as ATP*) as well as the LS and US positions. This cycling is linked to ATP hydrolysis, to the attachment position of ClpX pore-loops along the substrate, and to the interaction of ClpX IGF loops with ClpP. We begin our discussion of the unfolding/translocation cycle with the X1 protomer in Conformation A in the US position, detached from substrate and bridging the lowest and highest positions of the ClpX spiral. Both X1 and X6 protomers are ADP-bound, while the remaining protomers are in ATP-bound states. In Conformation B, X1 moves to the highest position of the spiral with respect to substrate (compare Figure 2F, top and bottom panels) simultaneously exchanging ADP for ATP in its nucleotide-binding pocket (Figure 5B). This transition brings X1 into close proximity with X2 and allows engagement of X1’s pore loops with substrate. The X1 pore-l loop now sits at the top of the spiral, two substrate residues above the X2 pore loop (Figure 5A and B), thereby translocating additional residues of substrate into the unfoldase. This transition also leads to release of substrate by X6, which pivots away from the central pore to adopt the LS position (second ring, Figure 5A). ATP hydrolysis and phosphate release by X5, which was in the ATP-hydrolysis primed ATP* state, restores the ClpX spiral back to the Conformation A state, (third ring of the four in Figure 5A), with X6 now assuming the US position. The complex is thus reset so that it can take another step along the substrate during the next A to B transition (third ring to fourth ring in Figure 5A). The cumulative effect of these transitions is a cycling of ClpX protomers through different positions on the spiral (Figure 5A and B). For example, the protomer initially in the US position (X1 in our discussion) will, with each step, move along the spiral such that it transitions from the US position to the top of the spiral (Conformation B) and then successively moving to lower spiral positions, through the ATP* state and finally the LS position, as substrate is translocated. Each Conformation A→Conformation B→Conformation A step results in the exchange of ADP for ATP and a single ATP hydrolysis event. Continuous repetition of these steps leads to a processive ‘hand-over-hand’ translocation of substrate through the axial pore of ClpX into ClpP (Illustrated in Video 2).

Figure 5. Translocation model for ClpXP.

Figure 5.

(A) Schematic of the ClpX-nucleotide-dependent conformational cycle. The transition from Conformation A to Conformation B is mediated through nucleotide exchange in the US position (1st to 2nd ring), with ATP hydrolysis and phosphate release in the ATP* position restoring the A conformation from the B state (2nd to 3rd ring) so that the cycle can repeat. In the new Conformation A (3rd ring), protomer X6 (yellow) adopts the US conformation and the X1 protomer (previous US) moves to the top of the spiral. In this way each protomer of the complex cycles through all positions as ATP is hydrolyzed in successively new ATP* protomer states, requiring the hydrolysis of seven ATPs. (B) Hand-over-hand mechanism of pore-loop mediated translocation. In the first A to B transition depicted in (A) X1 (US protomer) reengages at the top of the spiral and the LS pore one loop (X6 in Conformation B) disengages from the bottom of the spiral. As this is repeated the pore loops move ‘up’ the substrate and pull it into the degradation chamber. (C) IGF loop movements accompanying the hand-over-hand movements of ClpX. Shown in the small circles are the seven IGF-loop-binding sites in ClpP with a ‘+’ sign indicating engagement with an IGF loop of a given ClpX protomer. The binding sites are color coded according to the color of the protomer that interacts with the corresponding site. In conformation A, the IGF loop of X6 is unbound or only weakly bound, while in Conformation B it is bound. A new Conformation A is generated when the IGF loop from the ATP* protomer unbinds. It subsequently reengages with ClpP in a new Conformation B (third and fourth rings in (A)). In this way, the IGF loops ‘step’ around the ClpP ring, with each complete rotation requiring the hydrolysis of seven ATPs. (D) Schematic of the ClpX-ClpP interactions during seven ATP hydrolysis steps that lead to a net rotation of ClpX protomers by 60o. Because of the six- to seven-fold symmetry mismatch a total of forty-two ATPs must be hydrolyzed to return the protomers back to their original starting positions in the cycle (i.e. ring 1). Each of the seven ring structures corresponds to Conformation A, with the red arrows indicating the subsequent step of the IGF loop of the ATP* protomer along the cycle. The US protomer in each step is highlighted by the dashed trace.

Video 2. Hand-over-hand translocation cycle of the ClpXP complex.

Download video file (2.4MB, mp4)

Interpolation between states A → B → A → B. Side and top views of the complex are shown (top), along with the pore-1 loop Tyr153 and substrate (bottom left) as well as IGF loops (bottom right).

The sequential hydrolysis of ATP at the ATP* position results in unidirectional substrate translocation and movement of pore loops along the substrate (Figure 5B), with the counter clockwise hydrolysis cycle translating into a repeated downward pulling force on the substrate. Both the sequential hydrolysis of ATP as well as the ‘hand-over-hand’ substrate pulling model appear to be conserved for AAA+ unfoldases (Monroe et al., 2017; Yu et al., 2018; De la Peña et al., 2018; Shin et al., 2019; Ripstein et al., 2017).

The cycle described above, in which each protomer eventually adopts all positions in the spiral, has implications for how the IGF loops interact with the ClpP binding pockets. If the spiral position of each ClpX protomer was independent of IGF binding, alignment of the asymmetric ClpX spiral would lead to averaging of the IGF loops into all the pockets of ClpP during cryo-EM map refinement. However, our structures clearly show an empty IGF pocket on ClpP only between the ATP* and LS positions of Conformation B (Figure 2B), suggesting that this pocket must undergo a ‘cycle’ as well (Figure 5C). Thus, following ATP hydrolysis and phosphate release, the IGF loop of the protomer in the ATP* position (X5 initially) must leave its engaged pocket and move to bind the adjacent empty site on ClpP (red arrows in Figure 5C), as the complex transitions back to Conformation A (third ring in Figure 5A). In this state, the IGF loop appears not to have assumed a structure that allows for tight binding as only weak density is observed for it in EM maps. In contrast, strong binding is observed for this loop in Conformation B (Figure 4—figure supplement 1). Consistent with this model, the IGF loop of the X5 protomer has an ‘extended/stretched’ structure in the ATP* position of Conformation B (Figure 2F), which likely causes strain and facilitates loop release and subsequent binding to the corresponding site on the adjacent ClpP protomer (Figure 5C). After seven IGF loop release and reengagement events, accompanied by seven ATP hydrolysis steps, the ‘empty’ ClpP binding site makes a complete cycle, returning to its starting position (Figure 5C). The accompanying motion of ClpX on the apical surface of ClpP for a given IGF loop transition is complex and subtle, yet seven of these transitions lead to a net 60° rotation of ClpX with respect to ClpP (note the positions of the purple ClpX protomer in the first and seventh panels in Figure 5D; Video 3). The model described above is the simplest one that is consistent with our data. While our structures suggest that a sequential hydrolysis model exists for ClpXP, more complicated models can be envisioned that require additional states for which we have no experimental data. Indeed biochemical evidence suggests the possibility that when one or more subunits are catalytically deficient a more complex mechanism may be operational, allowing ClpXP to deviate from a strictly sequential hydrolysis scheme (Martin et al., 2008b).

Video 3. ClpX precession on the ClpP apical surface.

Download video file (14.5MB, mp4)

Repeated interpolation between states reveals a precession of the ClpX ring as its IGF loops are placed successively in different ClpP binding sites. The position of the empty binding pocket on ClpP undergoes a complete cycle around the complex for every 60o rotation of the ClpX ring relative to the ClpP ring.

During preparation of this manuscript, two manuscript preprints reported structures of ClpXP from L. monocytogenes (Gatsogiannis et al., 2019) and from E. coli (Fei et al., 2019), with ClpX resolutions ranging from 3.9 to 6 Å. While density maps and atomic models are not available for direct comparison with the NmClpXP, a few important similarities and differences are notable. In all species, the ClpX ring appears to adopt a similar offset relative to the symmetry axis of ClpP, indicating that the general architecture of the ClpXP machinery is conserved. Notably, however, the N-terminal apical loops of L. monocytogenes ClpP are not rigidified upon ClpX binding (Gatsogiannis et al., 2019), in contrast to the observation here that the gates rigidify upon binding to create a pore for substrate entry. In the case of L. monocytogenes ClpXP, unusual head-to-head dimers were observed that appeared to be mediated by the zinc binding domains. Despite the presence of the zinc-binding domains in our N. meningitidis construct, no such dimers were observed. While this difference may be due to differences across species, we note that the glutaraldehyde chemical crosslinker used to stabilize the L. monocytogenes ClpXP complex may have induced the formation of artefactual dimers.

Notably, substrate engagement is different between the ClpXP from N. meningitidis described here and from E. coli (Fei et al., 2019). In Conformation A seen with N. meningitidis, there is no engagement of substrate by any of the six pore-2 or six RKH loops, while in Conformation B only a single RKH loop and a single pore-2 loop contact substrate (Figure 3D and F). This observation is in contrast to the recently reported E. coli ClpXP structures (Fei et al., 2019) in which arginines located in the pore-2 loop from three to five different protomers (depending on the structure), as well as multiple RKH loops, form major contacts with substrate. The differences in these interactions may reflect the fact that while pore-1 loop and RKH loop motifs are critical for forming interactions with substrate, and in the case of pore-1 loops in particular, in providing the force for translocation, additional contacts may differ between species and may be necessary for recognition of degradation signals and for substrate specificity. The RKH loops are essential for the recognition of SsrA-tagged substrates by E. coli ClpX, while human ClpX, which substitutes the RKH sequence with an RKL tripeptide and contains pore-1 loops with the same sequence as E. coli ClpX, fails to recognize substrates with the SsrA-tag. Notably, however, an engineered human construct bearing the pore-2 and RKH loops of E. coli ClpX is able to unfold SsrA-tagged substrates (Farrell et al., 2007). Reordering of RKH loop residues to KHR and KRH results in significantly impaired substrate degradation (Fei et al., 2019) and a more disrupting AAA mutant does not support ClpP degradation of a SsrA-tagged substrate (Fei et al., 2019). Furthermore, the single point mutation RKH to RKA results in loss of activity for both SsrA and λO tagged substrates. The tight contact between H230 and the substrate in our maps provides a structural basis for understanding these mutagenesis results.

Although in the ClpXP structures from E. coli (Fei et al., 2019) the ClpX ring adopts the same spiral staircase arrangement observed in many AAA+ ATPases (Monroe et al., 2017; Yu et al., 2018; De la Peña et al., 2018; Shin et al., 2019; Ripstein et al., 2017; Enemark and Joshua-Tor, 2006; Huang et al., 2016), strongly supporting the ‘hand-over-hand’ mechanism of substrate translocation, the authors of this work instead posit a stochastic mechanism (Fei et al., 2019; Martin et al., 2005) for the HCLR clade of ATPases based on the observation of only a single bound ADP in their structures. In the stochastic model, only a single protomer pulls the substrate, via a state that has yet to be observed. Such a model, involving stochastic nucleotide hydrolysis, appears inconsistent with the observations here, with those for the related Lon protease (Shin et al., 2019) where two neighboring protomers are bound with ADP, and with a recent structural model for a substrate-bound E. coli ClpAP complex showing that the unbinding and rebinding of flexible IGL loops is coupled to substrate translocation as each protomer makes its way from the bottom to the top of the spiral (Lopez et al., 2019). The proposed mechanism in that case is similar to the one suggested here for N. meningitides ClpXP. The identification of two conformations in the N. meningitidis enzyme and observations of the bound nucleotides in each ClpX protomer leads to a simple model of cyclic hydrolysis that, in turn, results in unidirectional substrate translocation. In this model, the substrate is always gripped by multiple protomers, with only a single protomer disengaged as it traverses from the bottom to the top of the spiral. While unique features will undoubtedly continue to emerge regarding subtle functional aspects of different AAA+ unfoldases it is likely that the translocating forces generated by these molecular machines are based on a common mechanism.

Materials and methods

Key resources table.

Reagent type
(species) or resource
Designation Source or reference Identifiers Additional
information
Gene (Neisseria meningitidis) clpX UniProtKB - Q9JYY3
Gene (Neisseria meningitidis) clpP UniProtKB - Q9JZ38
Strain, strain background (Escherichia coli) BL21(DE3) Sigma-Aldrich CMC0016 Chemically competent cells
Recombinant DNA reagent pET28-NmClpP Synthetic
(GenScript)
UniProtKB - Q9JYY3 Plasmid containing ClpP
Recombinant DNA reagent pET28a-NmClpX Synthetic
(GenScript)
UniProtKB - Q9JZ38 Plasmid containing ClpX
Recombinant DNA reagent pET28a-
GFP-SsrA
(Ripstein et al., 2017) Plasmid containing GFP-SsrA
Chemical compound, drug PKM-AMC GenScript Fluorogenic peptide for protease assays
Software, algorithm EPU Thermo Fischer Scientific EM imaging software
Software, algorithm cryoSPARC v2 (Punjani et al., 2017) RRID:SCR_016501 EM reconstruction software
Software, algorithm UCSF Chimera (Pettersen et al., 2004) RRID:SCR_004097 Molecular Visualization
Software
Software, algorithm UCSF ChimeraX (Goddard et al., 2018) RRID:SCR_015872 Molecular Visualization
Software
Software, algorithm Coot (Emsley and Cowtan, 2004) RRID:SCR_014222 Protein Model Building Software
Software, algorithm Phyre2 (Kelley et al., 2015) RRID:SCR_010270 Protein Model Building Software
Software, algorithm Rosetta (Wang et al., 2015) RRID:SCR_015701 Protein Model Building Software
Software, algorithm Phenix (Adams et al., 2010) RRID:SCR_014224 Protein Model Building Software
Software, algorithm Molprobity (Arendall III et al., 2010) RRID:SCR_014226 Protein Model Evaluation Software
Software, algorithm EMRinger (Barad et al., 2015) Protein Model Evaluation Software

Plasmids and constructs 

Codon-optimized genes encoding NmClpX (Uniprot entry: Q9JYY3) bearing an N-terminal His6-TEV affinity tag and ClpP (Uniprot entry: Q9JZ38) with an N-terminal His6-SUMO tag were synthesized by GenScript (Piscataway, NJ) and cloned into the NdeI and BamHI sites of pET28a+ (Novagen, Madison, WI). Point mutations were introduced with the Quikchange mutagenesis method (Agilent, Santa Clara, CA).

Expression and purification of NmClpP and NmClpX 

Transformed Codon+ E. coli BL21(DE3) cells were grown in LB media at 37°C. Protein over-expression was induced by addition of 0.2 mM IPTG at OD600 = 1.0 and was allowed to proceed overnight at 18°C. Cells were lysed in buffer containing 50 mM Tris, 300 KCl, 10 mM imidazole, 10% glycerol, pH 7.0 and NmClpP and NmClpX proteins purified by Ni-affinity chromatography [HisTrap HP (GE)] in lysis buffer. Bound proteins were eluted from the Ni column by increasing the imidazole concentration to 500 mM. The affinity tag was removed by the addition of TEV (for ClpX) or Ulp1 (for ClpP) protease followed by dialysis against lysis/wash buffer that included 5 mM DTT. Following a reverse Ni-affinity chromatography step, the flow-through, free from the cleaved tag and other impurities, was concentrated with an Amicon Ultra-15 50K MWCO (Millipore) concentrator and subjected to size exclusion chromatography (SEC) with a Superdex 200 Increase 10/300 (GE) column in SEC buffer (50 mM imidazole, 100 mM KCl, 5 mM DTT, pH 7.0). Fractions corresponding to NmClpX and NmClpP were pooled and stored at 4°C in the SEC buffer until further use. Salts containing magnesium were avoided during the purification of NmClpX to prevent protein aggregation. Protein concentrations were determined in 8 M GdnCl using extinction coefficient values (7450 M−1 cm−1 for ClpP, 8940 M−1 cm−1 for ClpX) determined with ExPASy’s ProtParam (Gasteiger et al., 2005).

Expression and purification of GFP-SsrA

Green fluorescent protein (GFP) bearing an 11-residue SsrA degradation tag at its carboxyl terminus and a non-cleavable N-terminal His × 6 tag was purified by Ni affinity chromatography followed by SEC on a HiLoad 16/60 Superdex 75 pg column (GE).

Peptidase rate measurements of NmClpP as a function of pH

The peptidase activity of NmClpP was measured at 37°C with Acetyl-L-Pro-L-Lys-L-Met bearing a C-terminal fluorogenic 7-amino-4-methylcoumarin group (PKM-AMC) as substrate. The reaction was followed with a Synergy Neo2 96-well microplate reader making a measurement every 21 s for 60 min at λex: 355 nm, λem: 460 nm. Each well contained 1 μM NmClpP (monomer concentration), 250 μM PKM-AMC, 50 mM citrate, 50 mM phosphate, 50 mM Tris, 100 mM KCl in a total volume of 100 μL adjusted to the appropriate pH. Activities are derived from initial rates extracted and analyzed using a python script written in-house. Standard errors are calculated from repeating each reaction in triplicate.

GFP-SsrA degradation assays

Degradation of 1 μM samples of GFP-SsrA was followed by the loss of GFP fluorescence (λex: 480 nm, λem: 508 nm) with a Synergy Neo2 96-well microplate reader at 25°C. The wells included an ATP-regeneration system (Nørby, 1988) that contained 1.5 mM phosphoenolpyruvate, 0.2 mM NADH, 40 μg/mL pyruvate kinase, 40 μg/mL lactate dehydrogenase, and 2 mM MgATP at pH 8.2. In some assays, solutions also contained WT NmClpX at 0.5 μM (hexamer) and/or WT ClpP at a 0.25 μM (tetradecamer), as indicated in Figure 1B. All assays were performed in triplicate.

Preparation of samples for cryo-EM

A 1 mL mixture containing 10 μM (tetradecamer) NmClpP and 20 μM NmClpX together with 200 μM GFP-SsrA was incubated with 20 mM MgATP for 10 min at room temperature. This mixture was applied to a Superdex 200 Increase 10/300 (GE) column equilibrated with 50 mM bicine, 100 mM KCl, 2 mM MgATP, pH adjusted to 8.2 at room temperature (equivalent to pH 8.5 at 4°C – see Appendix 1—figure 1), as the running buffer. Following SEC, a 0.5 mL fraction (denoted with a * in Figure 1—figure supplement 1) containing doubly capped ClpXP bound to GFP-SsrA was supplemented with 20 μM GFP-SsrA and vitrified immediately without the addition of any cross-linking agent or detergent.

Sample vitrification

2.5 μL of the sample mixtures were applied to nanofabricated holey gold grids (Marr et al., 2014; Russo and Passmore, 2014; Meyerson et al., 2015) with a hole size of ~1 μm, that had been glow discharged in air for 15 s. Grids were blotted on both sides using a FEI Vitrobot mark III for 15 s at 4°C and ~100% relative humidity before freezing in a liquid ethane/propane mixture (Tivol et al., 2008).

Electron microscopy

NmClpXP was imaged with a Thermo Fisher Scientific Titan Krios G3 microscope operating at 300 kV and equipped with a FEI Falcon III DDD camera. Structures were calculated from counting mode movies consisting of 30 frames, obtained over a 60 s exposure with defocuses ranging from 0.9 to 1.7 μm. Movies were at a nominal magnification of 75,000 × corresponding to a calibrated pixel size of 1.06 Å and with an exposure of 0.8 electrons/pixel/s, giving a total exposure of 43 electrons/Å2. 2680 movies were collected using the microscope’s EPU software. The Apo-NmClpP structure (with no ClpX or GFP present) was calculated from data obtained using a FEI Tecnai F20 electron microscope operating at 200 kV and equipped with a Gatan K2 Summit direct detector device camera. Movies consisting of 30 frames over a 15 s exposure were obtained with defocuses ranging from 1.7 to 2.9 μm. Movies were collected in counting mode at a nominal magnification of 25,000 × corresponding to a calibrated pixel size of 1.45 Å and with an exposure of 5 electrons/pixel/s, and a total exposure of 35 electrons/Å2. 122 movies were collected using Digital Micrograph software.

EM image analysis

Patch based whole frame alignment and exposure weighting was performed in cryoSPARC v2 (Punjani et al., 2017) with a 10 × 10 grid and the resulting averages of frames were used for patch based contrast transfer function (CTF) determination. Templates for particle selection were generated by 2D classification of manually selected particles. Particle images were extracted in 300 × 300 pixel boxes for further analysis. Ab inito map calculation was performed on a random subset of 30,000 particle images, generating an initial map showing density for the complex of a ClpP tetradecamer bound to two ClpX hexamers. A single round of 2D classification was used to remove images of damaged particles and other contaminants from a dataset of 466,549 particle images, with selected classes leaving 377,234 particle images for further analysis. Homogeneous refinement of these particle images using D7 symmetry yielded a map of the complex, with good density for only the ClpP portion, at 2.3 Å resolution.

To improve the density of the ClpX portion of the map, a round of Ab initio classification was performed using three classes, of which two classes containing 289,144 particle images had good density for ClpX, with the remaining class containing mostly density for ClpP. Refinement of these particle images with C1 symmetry resulted in a map of the ClpXP complex at a nominal resolution of 2.8 Å, but with poorly defined density for much of ClpX. To improve the interpretability of the map in the ClpX region, local refinement was performed with a mask around the six ClpX subunits without performing signal subtraction for ClpP. This refinement greatly improved the map in the ClpX region, while blurring the density at the distal ClpP ring (indicative of flexibility between ClpX and ClpP). However, density for two of the ClpX subunits remained fragmented and at lower resolution. To help resolve the heterogeneity of this region ‘3D variability analysis’ was performed, which utilizes principle component analysis to separate conformations. Clustering was performed along three eigenvectors. Two clusters were identified along a single eigenvector corresponding to two conformations of ClpX bound to substrate. From the trajectory identified, the two endpoints were used to seed a heterogeneous classification in which the O-EM learning rate was reduced 10-fold to preserve the original character of the seeds yielding two classes split ~40%:60% with 110,696 and 178,448 particle images for Conformations A and B respectively. Subsequent non-uniform refinement yielded maps at 3.3 Å and 2.9 Å respectively, which were then used for model building.

For Apo-NmClpP the same preprocessing steps were applied as described above, and 100,132 particle images were extracted in 160 × 160 pixel boxes for further analysis. Rounds of 2D classification and ab initio classification led to a subset of 50,400 particle images that were used to refined a map to 4.1 Å resolution.

Atomic model building and refinement

To model NmClpP, the crystal structure of NmClpP (PDBID: 5DKP) (Goodreid et al., 2016) was rigidly fit with UCSF Chimera (Pettersen et al., 2004) into the 2.3 Å D7 symmetric map, followed by relaxation with Rosetta using the density map as an additional term in the scoring function (Wang et al., 2015), and utilizing D7 non crystallographic symmetry. The best scoring model was then rigidly fit into the C1 symmetry focussed maps for Conformations A and B. Visual inspection and real space refinement in Coot (Emsley and Cowtan, 2004) was then used to better fit the model into the density where it deviated from the ideal symmetry version, specifically in areas where ClpX contacted ClpP, and the apical loops (N-terminal β-hairpins).

For NmClpX, Phyre2 (Kelley et al., 2015) was used to perform one-to-one threading onto the previous crystal structure of ClpX from E. coli (PDBID 3HWS chain A) (Glynn et al., 2009). A single chain was then rigidly docked into the X3 position of the 2.9 Å map, and real space refinement and Ab initio model building of regions that poorly fit the density, as well as for regions missing from the homology model was performed in Coot (Emsley and Cowtan, 2004). This model was then relaxed with Rosetta (Wang et al., 2015), and rigidly fit into the density for the other five ClpX protomers. Iterative rounds of real space refinement and Ab initio model building in Coot (Emsley and Cowtan, 2004), relaxation in Rosetta (Wang et al., 2015), and real space refinement in Phenix (Adams et al., 2010), were then used to create the final model. To model Conformation A, the model for Conformation B was used as a starting point before iterative rounds of real space refinement and Ab initio model building in Coot, relaxation in Rosetta, and real space refinement in Phenix. While the experimental density for the substrate showed some bulky side chains, attempts to register the SsrA sequence in the density were unsuccessful and the substrate was modeled as polyalanine. Models were evaluated with Molprobity (Arendall III et al., 2010) and EMRinger (Barad et al., 2015Table 1). Figures and movies were generated in UCSF Chimera (Pettersen et al., 2004) and UCSF ChimeraX (Goddard et al., 2018), and colors chosen with ColorBrewer (Harrower and Brewer, 2003).

Table 1. Cryo-EM data acquisition, processing, atomic model statistics, and map/model depositions.

A. Cryo-EM data acquisition and image processing.
Data collection
NmClpXP + GFP-SsrA apo-NmClpP
Electron Microscope Titan Krios Tecnai F20
Camera Falcon 3EC K2 Summit
Voltage (kV) 300 200
Nominal Magnification 75,000 25,000
Calibrated physical pixel size (Å) 1.06 1.45
Total exposure (e/Å2) 42.7 35
Exposure rate (e/pixel/s) 0.8 5
Number of frames 30 30
Defocus range (μm) 0.9 to 1.7 0.8 to 3.3
Image processing
Motion correction software cryoSPARC v2 cryoSPARC v2
CTF estimation software cryoSPARC v2 cryoSPARC v2
Particle selection software cryoSPARC v2 cryoSPARC v2
Micrographs used 2680 122
Particle images selected 466,549 100,132
3D map classification and refinement software cryoSPARC v2 cryoSPARC v2
B. Map and model statistics.
EM maps NmClpXP with Symmetry Focused NmClpX
Conformation A
Focused NmClpX
Conformation B
Apo-NmClpP
Particle images contributing to maps 377,234 110,696 178,448 50,403
Applied symmetry D7 C1 C1 D7
Applied B-factor (Å2) −116.2 −84.1 −88.1 −229.7
Global resolution (FSC = 0.143, Å) 2.3 3.3 2.9 4.1
Model Building NmClpX Conformation A focused NmClpX Conformation B focused NmClpP with
Symmetry
NmClpXP
Conformation A combined
NmClpXP
Conformation B combined
Modeling software Coot, Phenix, Rosetta
Number of residues 1912 2018 2671 4583 4689
RMS bond length (Å) 0.0043 0.0037 0.0039 0.0044 0.0038
RMS bond angle (°) 1.04 0.93 0.91 1.00 0.92
Ramachandaran outliers (%) 0.00 0.05 0.00 0.00 0.02
Ramachandran favored (%) 98.33 97.32 95.68 97.07 96.39
Rotamer outliers 0.25 0.24 0.00 0.13 0.10
C-beta deviations 0 0 0 0 0
Clashscore 1.45 2.8 0.67 1.84 2.11
MolProbity score 0.88 1.20 1.02 1.11 1.22
EMRinger score 2.78 3.42 5.6
Map-Model CC_mask 0.75 0.78 0.82
Ligand 2 ADP
4 Mg-ATP
1 ADP
5 Mg-ATP
2 ADP
4 Mg-ATP
1 ADP
5 Mg-ATP
C. Residues excluded in atomic models*.
ClpX protomer NmClpXP
Conformation A combined
NmClpXP
Conformation B combined
X1 (Chain A) 1–62, 102–109, 149–156, 191–204, 224–236, 263–264, 273–282, 413–414 1–62, 228–233, 275–278, 413–414
X2 (Chain B) 1–62, 102–111, 192–198, 226–235, 275–279, 413–414 1–62, 226–233, 275–279, 413–414
X3 (Chain C) 1–62, 192–198, 225–232, 275–279, 413–414 1–62, 192–198, 228–233, 274–278, 413–414
X4 (Chain D) 1–62, 103–106, 193–198, 226–234, 276–280, 413–414 1–62, 193–198, 229–233, 413–414
X5 (Chain E) 1–62, 193–198, 229–233, 277–281, 413–414 1–62, 193–198, 277–279, 413–414
X6 (Chain F) 1–62, 193–201, 225–234, 259–287, 413–414 1–62, 191–204, 227–233, 275–282, 413–414
ClpP subunits NmClpXP
Conformation A combined
NmClpXP
Conformation B combined
Chain H 1–5, 16–18, 199–204 1–5, 16–18, 199–204
Chain I 1–5, 16–17, 199–204 1–5, 16–17, 199–204
Chain J 1–5, 17, 199–204 1–5, 17, 199–204
Chain K 1–5, 199–204 1–5, 199–204
Chain L 1–5, 16–17, 199–204 1–5, 16–17, 199–204
Chain M 1–5, 13–19, 199–204 1–5, 13–19, 199–204
Chain N 1–5, 16–17, 199–204 1–5, 16–17, 199–204
Chain O 1–5, 16–17, 199–204 1–5, 16–17, 199–204
Chain P 1–5, 16–17, 199–204 1–5, 16–17, 199–204
Chain Q 1–5, 16–17, 199–204 1–5, 16–17, 199–204
Chain R 1–5, 16–17, 199–204 1–5, 16–17, 199–204
Chain S 1–5, 16–17, 199–204 1–5, 16–17, 199–204
Chain T 1–5, 16–17, 199–204 1–5, 16–17, 199–204
Chain U 1–5, 16–17, 199–204 1–5, 16–17, 199–204
D. Deposited maps and associated coordinate files.
Maps EMDB code Associated PDB ID
NmClpXP Conformation A EMD-21187 6VFS
NmClpXP Conformation B EMD-21194 6VFX
NmClpXP D7 EMD-21195
Apo-NmClpP EMD-21196

*Protomer X1 is US in Conformation A and protomer X2 is LS in Conformation B.

Acknowledgements

We thank Dr. Samir Benlekbir for cryo-EM data collection on the Titan Krios. The authors are grateful to Professor Andreas Martin for helpful discussions. ZAR and SV were supported by a scholarship and a postdoctoral fellowship from the Canadian Institutes of Health Research, respectively. LEK and JLR were supported by the Canada Research Chairs program. This research was funded by Canadian Institutes of Health Research grants FDN-503573 (LEK), PJT-162186 (JLR), and PJT-148564 (WAH). Titan Krios cryo-EM data were collected at the Toronto High-Resolution High-Throughput cryo-EM facility supported by the Canadian Foundation for Innovation and Ontario Research Fund.

Appendix 1

Appendix 1—figure 1. Peptidase rate measurements of NmClpP as a function of pH, monitored using the fluorogenic substrate PKM-AMC.

Appendix 1—figure 1.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Zev A Ripstein, Email: zevripstein@gmail.com.

Siavash Vahidi, Email: svahidi@pound.med.utoronto.ca.

John L Rubinstein, Email: john.rubinstein@sickkids.ca.

Lewis E Kay, Email: kay@pound.med.utoronto.ca.

Axel T Brunger, Stanford University, United States.

John Kuriyan, University of California, Berkeley, United States.

Funding Information

This paper was supported by the following grants:

  • Canadian Institutes of Health Research FDN-503573 to Lewis E Kay.

  • Canadian Institutes of Health Research PJT-162186 to John L Rubinstein.

  • Canadian Institutes of Health Research PJT-148564 to Walid A Houry.

  • Canadian Institutes of Health Research to Zev A Ripstein, Siavash Vahidi.

  • Canada Research Chairs to Lewis E Kay, John L Rubinstein.

Additional information

Competing interests

Reviewing editor, eLife.

No competing interests declared.

Author contributions

Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology.

Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology.

Conceptualization, Writing - review and editing.

Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology.

Conceptualization, Resources, Supervision, Funding acquisition, Investigation, Project administration.

Additional files

Transparent reporting form

Data availability

CryoEM maps and models have been deposited in the EMDB and PDB.

The following datasets were generated:

Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation A. RCSB Protein Data Bank. 6VFS

Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation B. RCSB Protein Data Bank. 6VFX

Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation A. Electron Microscopy Data Bank. EMD-21187

Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation B. Electron Microscopy Data Bank. EMD-21194

Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP D7. Electron Microscopy Data Bank. EMD-21195

Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps Apo-NmClpP. Electron Microscopy Data Bank. EMD-21196

References

  1. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallographica Section D Biological Crystallography. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amor AJ, Schmitz KR, Baker TA, Sauer RT. Roles of the ClpX IGF loops in ClpP association, dissociation, and protein degradation. Protein Science. 2019;28:756–765. doi: 10.1002/pro.3590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arendall III JJ, Headd DA, Keedy RM, Immormino GJ, Kapral LW, Murray JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallographica. 2010;66:12–21. doi: 10.1107/s0907444909042073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Augustyniak R, Kay LE. Cotranslocational processing of the protein substrate calmodulin by an AAA+ unfoldase occurs via unfolding and refolding intermediates. PNAS. 2018;115:E4786–E4795. doi: 10.1073/pnas.1721811115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baker TA, Sauer RT. ClpXP, an ATP-powered unfolding and protein-degradation machine. Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research. 2012;1823:15–28. doi: 10.1016/j.bbamcr.2011.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barad BA, Echols N, Wang RY, Cheng Y, DiMaio F, Adams PD, Fraser JS. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nature Methods. 2015;12:943–946. doi: 10.1038/nmeth.3541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beuron F, Maurizi MR, Belnap DM, Kocsis E, Booy FP, Kessel M, Steven AC. At sixes and sevens: characterization of the symmetry mismatch of the ClpAP chaperone-assisted protease. Journal of Structural Biology. 1998;123:248–259. doi: 10.1006/jsbi.1998.4039. [DOI] [PubMed] [Google Scholar]
  8. Bewley MC, Graziano V, Griffin K, Flanagan JM. The asymmetry in the mature amino-terminus of ClpP facilitates a local symmetry match in ClpAP and ClpXP complexes. Journal of Structural Biology. 2006;153:113–128. doi: 10.1016/j.jsb.2005.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bhandari V, Wong KS, Zhou JL, Mabanglo MF, Batey RA, Houry WA. The role of ClpP protease in bacterial pathogenesis and human diseases. ACS Chemical Biology. 2018;13:1413–1425. doi: 10.1021/acschembio.8b00124. [DOI] [PubMed] [Google Scholar]
  10. Böttcher T, Sieber SA. Beta-lactones as privileged structures for the active-site labeling of versatile bacterial enzyme classes. Angewandte Chemie International Edition. 2008;47:4600–4603. doi: 10.1002/anie.200705768. [DOI] [PubMed] [Google Scholar]
  11. Choules MP, Wolf NM, Lee H, Anderson JR, Grzelak EM, Wang Y, Ma R, Gao W, McAlpine JB, Jin Y-Y, Cheng J, Lee H, Suh J-W, Duc NM, Paik S, Choe JH, Jo E-K, Chang CL, Lee JS, Jaki BU, Pauli GF, Franzblau SG, Cho S. Rufomycin targets ClpC1 proteolysis in Mycobacterium tuberculosis and M. abscessus. Antimicrobial Agents and Chemotherapy. 2019;63:e02204. doi: 10.1128/AAC.02204-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Culp E, Wright GD. Bacterial proteases, untapped antimicrobial drug targets. The Journal of Antibiotics. 2017;70:366–377. doi: 10.1038/ja.2016.138. [DOI] [PubMed] [Google Scholar]
  13. De la Peña AH, Goodall EA, Gates SN, Lander GC, Martin A. Substrate-engaged 26S proteasome structures reveal mechanisms for ATP-hydrolysis-driven translocation. Science. 2018;362:eaav0725. doi: 10.1126/science.aav0725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Effantin G, Maurizi MR, Steven AC. Binding of the ClpA unfoldase opens the axial gate of ClpP peptidase. Journal of Biological Chemistry. 2010;285:14834–14840. doi: 10.1074/jbc.M109.090498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallographica. Section D, Biological Crystallography. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
  16. Enemark EJ, Joshua-Tor L. Mechanism of DNA translocation in a replicative hexameric helicase. Nature. 2006;442:270–275. doi: 10.1038/nature04943. [DOI] [PubMed] [Google Scholar]
  17. Farrell CM, Baker TA, Sauer RT. Altered specificity of a AAA+ protease. Molecular Cell. 2007;25:161–166. doi: 10.1016/j.molcel.2006.11.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fei X, Bell TA, Jenni S, Stinson BM, Baker TA, Harrison SC, Sauer RT. Structures of the ATP-fueled ClpXP proteolytic machine bound to protein substrate. bioRxiv. 2019 doi: 10.1101/704999. [DOI] [PMC free article] [PubMed]
  19. Fetzer C, Korotkov VS, Thänert R, Lee KM, Neuenschwander M, von Kries JP, Medina E, Sieber SA. A chemical disruptor of the ClpX chaperone complex attenuates the virulence of Multidrug-Resistant Staphylococcus aureus. Angewandte Chemie International Edition. 2017;56:15746–15750. doi: 10.1002/anie.201708454. [DOI] [PubMed] [Google Scholar]
  20. Förster F, Unverdorben P, Sledź P, Baumeister W. Unveiling the long-held secrets of the 26S proteasome. Structure. 2013;21:1551–1562. doi: 10.1016/j.str.2013.08.010. [DOI] [PubMed] [Google Scholar]
  21. Frees D, Gerth U, Ingmer H. Clp chaperones and proteases are central in stress survival, virulence and antibiotic resistance of Staphylococcus aureus. International Journal of Medical Microbiology. 2014;304:142–149. doi: 10.1016/j.ijmm.2013.11.009. [DOI] [PubMed] [Google Scholar]
  22. Gao W, Kim J-Y, Anderson JR, Akopian T, Hong S, Jin Y-Y, Kandror O, Kim J-W, Lee I-A, Lee S-Y, McAlpine JB, Mulugeta S, Sunoqrot S, Wang Y, Yang S-H, Yoon T-M, Goldberg AL, Pauli GF, Suh J-W, Franzblau SG, Cho S. The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo. Antimicrobial Agents and Chemotherapy. 2015;59:880–889. doi: 10.1128/AAC.04054-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A. Protein Identification and Analysis Tools on the ExPASy Server. In: Walker N. J, editor. The Proteomics Protocols Handbook. Humana Press; 2005. pp. 571–607. [DOI] [Google Scholar]
  24. Gates SN, Yokom AL, Lin J, Jackrel ME, Rizo AN, Kendsersky NM, Buell CE, Sweeny EA, Mack KL, Chuang E, Torrente MP, Su M, Shorter J, Southworth DR. Ratchet-like polypeptide translocation mechanism of the AAA+ disaggregase Hsp104. Science. 2017;357:273–279. doi: 10.1126/science.aan1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Gatsogiannis C, Balogh D, Merino F, Sieber SA, Raunser S. Cryo-EM structure of the ClpXP protein degradation machinery. bioRxiv. 2019 doi: 10.1101/638692. [DOI] [PMC free article] [PubMed]
  26. Gavrish E, Sit CS, Cao S, Kandror O, Spoering A, Peoples A, Ling L, Fetterman A, Hughes D, Bissell A, Torrey H, Akopian T, Mueller A, Epstein S, Goldberg A, Clardy J, Lewis K. Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chemistry & Biology. 2014;21:509–518. doi: 10.1016/j.chembiol.2014.01.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Geiger SR, Böttcher T, Sieber SA, Cramer P. A conformational switch underlies ClpP protease function. Angewandte Chemie International Edition. 2011;50:5749–5752. doi: 10.1002/anie.201100666. [DOI] [PubMed] [Google Scholar]
  28. Gersch M, Famulla K, Dahmen M, Göbl C, Malik I, Richter K, Korotkov VS, Sass P, Rübsamen-Schaeff H, Madl T, Brötz-Oesterhelt H, Sieber SA. AAA+ chaperones and acyldepsipeptides activate the ClpP protease via conformational control. Nature Communications. 2015;6:6320. doi: 10.1038/ncomms7320. [DOI] [PubMed] [Google Scholar]
  29. Glynn SE, Martin A, Nager AR, Baker TA, Sauer RT. Structures of asymmetric ClpX hexamers reveal nucleotide-dependent motions in a AAA+ protein-unfolding machine. Cell. 2009;139:744–756. doi: 10.1016/j.cell.2009.09.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Goard CA, Schimmer AD. Mitochondrial matrix proteases as novel therapeutic targets in malignancy. Oncogene. 2014;33:2690–2699. doi: 10.1038/onc.2013.228. [DOI] [PubMed] [Google Scholar]
  31. Goddard TD, Huang CC, Meng EC, Pettersen EF, Couch GS, Morris JH, Ferrin TE. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Science. 2018;27:14–25. doi: 10.1002/pro.3235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;426:895–899. doi: 10.1038/nature02263. [DOI] [PubMed] [Google Scholar]
  33. Goodreid JD, Janetzko J, Santa Maria JP, Wong KS, Leung E, Eger BT, Bryson S, Pai EF, Gray-Owen SD, Walker S, Houry WA, Batey RA. Development and characterization of potent cyclic acyldepsipeptide analogues with increased antimicrobial activity. Journal of Medicinal Chemistry. 2016;59:624–646. doi: 10.1021/acs.jmedchem.5b01451. [DOI] [PubMed] [Google Scholar]
  34. Gribun A, Kimber MS, Ching R, Sprangers R, Fiebig KM, Houry WA. The ClpP double ring tetradecameric protease exhibits plastic ring-ring interactions, and the N termini of its subunits form flexible loops that are essential for ClpXP and ClpAP complex formation. Journal of Biological Chemistry. 2005;280:16185–16196. doi: 10.1074/jbc.M414124200. [DOI] [PubMed] [Google Scholar]
  35. Grimaud R, Kessel M, Beuron F, Steven AC, Maurizi MR. Enzymatic and structural similarities between the Escherichia coli ATP-dependent proteases, ClpXP and ClpAP. Journal of Biological Chemistry. 1998;273:12476–12481. doi: 10.1074/jbc.273.20.12476. [DOI] [PubMed] [Google Scholar]
  36. Hackl MW, Lakemeyer M, Dahmen M, Glaser M, Pahl A, Lorenz-Baath K, Menzel T, Sievers S, Böttcher T, Antes I, Waldmann H, Sieber SA. Phenyl esters are potent inhibitors of caseinolytic protease P and reveal a stereogenic switch for deoligomerization. Journal of the American Chemical Society. 2015;137:8475–8483. doi: 10.1021/jacs.5b03084. [DOI] [PubMed] [Google Scholar]
  37. Harrower M, Brewer CA. ColorBrewer.org: an online tool for selecting colour schemes for maps. The Cartographic Journal. 2003;40:27–37. doi: 10.1179/000870403235002042. [DOI] [Google Scholar]
  38. Hersch GL, Burton RE, Bolon DN, Baker TA, Sauer RT. Asymmetric interactions of ATP with the AAA+ ClpX6 unfoldase: allosteric control of a protein machine. Cell. 2005;121:1017–1027. doi: 10.1016/j.cell.2005.05.024. [DOI] [PubMed] [Google Scholar]
  39. Huang R, Ripstein ZA, Augustyniak R, Lazniewski M, Ginalski K, Kay LE, Rubinstein JL. Unfolding the mechanism of the AAA+ unfoldase VAT by a combined cryo-EM, solution NMR study. PNAS. 2016;113:E4190–E4199. doi: 10.1073/pnas.1603980113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ishizawa J, Zarabi SF, Davis RE, Halgas O, Nii T, Jitkova Y, Zhao R, St-Germain J, Heese LE, Egan G, Ruvolo VR, Barghout SH, Nishida Y, Hurren R, Ma W, Gronda M, Link T, Wong K, Mabanglo M, Kojima K, Borthakur G, MacLean N, Ma MCJ, Leber AB, Minden MD, Houry W, Kantarjian H, Stogniew M, Raught B, Pai EF, Schimmer AD, Andreeff M. Mitochondrial ClpP-Mediated proteolysis induces selective Cancer cell lethality. Cancer Cell. 2019;35:721–737. doi: 10.1016/j.ccell.2019.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Jennings LD, Bohon J, Chance MR, Licht S. The ClpP N-terminus coordinates substrate access with protease active site reactivity. Biochemistry. 2008;47:11031–11040. doi: 10.1021/bi8010169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Jones JM, Welty DJ, Nakai H. Versatile action of Escherichia coli ClpXP as protease or molecular chaperone for bacteriophage mu transposition. Journal of Biological Chemistry. 1998;273:459–465. doi: 10.1074/jbc.273.1.459. [DOI] [PubMed] [Google Scholar]
  43. Joshi SA, Hersch GL, Baker TA, Sauer RT. Communication between ClpX and ClpP during substrate processing and degradation. Nature Structural & Molecular Biology. 2004;11:404–411. doi: 10.1038/nsmb752. [DOI] [PubMed] [Google Scholar]
  44. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2 web portal for protein modeling, prediction and analysis. Nature Protocols. 2015;10:845–858. doi: 10.1038/nprot.2015.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Kessel M, Maurizi MR, Kim B, Kocsis E, Trus BL, Singh SK, Steven AC. Homology in structural organization between E. coli ClpAP protease and the eukaryotic 26 S proteasome. Journal of Molecular Biology. 1995;250:587–594. doi: 10.1006/jmbi.1995.0400. [DOI] [PubMed] [Google Scholar]
  46. Kim YI, Levchenko I, Fraczkowska K, Woodruff RV, Sauer RT, Baker TA. Molecular determinants of complex formation between clp/Hsp100 ATPases and the ClpP peptidase. Nature Structural Biology. 2001;8:230–233. doi: 10.1038/84967. [DOI] [PubMed] [Google Scholar]
  47. Kirstein J, Hoffmann A, Lilie H, Schmidt R, Rübsamen-Waigmann H, Brötz-Oesterhelt H, Mogk A, Turgay K. The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. EMBO Molecular Medicine. 2009;1:37–49. doi: 10.1002/emmm.200900002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Kish-Trier E, Hill CP. Structural biology of the proteasome. Annual Review of Biophysics. 2013;42:29–49. doi: 10.1146/annurev-biophys-083012-130417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Lakemeyer M, Bertosin E, Möller F, Balogh D, Strasser R, Dietz H, Sieber SA. Tailored peptide phenyl esters block ClpXP proteolysis by an unusual breakdown into a Heptamer-Hexamer assembly. Angewandte Chemie International Edition. 2019;58:7127–7132. doi: 10.1002/anie.201901056. [DOI] [PubMed] [Google Scholar]
  50. Lee ME, Baker TA, Sauer RT. Control of substrate gating and translocation into ClpP by channel residues and ClpX binding. Journal of Molecular Biology. 2010;399:707–718. doi: 10.1016/j.jmb.2010.04.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Li DH, Chung YS, Gloyd M, Joseph E, Ghirlando R, Wright GD, Cheng YQ, Maurizi MR, Guarné A, Ortega J. Acyldepsipeptide antibiotics induce the formation of a structured axial channel in CIpP: a model for the CIpX/CIpA-Bound state of CIpP. Chemistry & Biology. 2010;17:959–969. doi: 10.1016/j.chembiol.2010.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Li M, Kandror O, Akopian T, Dharkar P, Wlodawer A, Maurizi MR, Goldberg AL. Structure and functional properties of the active form of the proteolytic complex, ClpP1P2, from Mycobacterium tuberculosis. Journal of Biological Chemistry. 2016;291:7465–7476. doi: 10.1074/jbc.M115.700344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Liu K, Ologbenla A, Houry WA. Dynamics of the ClpP serine protease: a model for self-compartmentalized proteases. Critical Reviews in Biochemistry and Molecular Biology. 2014;49:400–412. doi: 10.3109/10409238.2014.925421. [DOI] [PubMed] [Google Scholar]
  54. Lopez KE, Rizo AN, Tse E, Lin J, Scull NW, Thwin AC, Lucius AL, Shorter J, Southworth DR. Conformational plasticity of the ClpAP AAA+ protease couples protein unfolding and proteolysis. bioRxiv. 2019 doi: 10.1101/820209. [DOI] [PMC free article] [PubMed]
  55. Mabanglo MF, Leung E, Vahidi S, Seraphim TV, Eger BT, Bryson S, Bhandari V, Zhou JL, Mao YQ, Rizzolo K, Barghash MM, Goodreid JD, Phanse S, Babu M, Barbosa LRS, Ramos CHI, Batey RA, Kay LE, Pai EF, Houry WA. ClpP protease activation results from the reorganization of the electrostatic interaction networks at the entrance pores. Communications Biology. 2019;2:410. doi: 10.1038/s42003-019-0656-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Majumder P, Rudack T, Beck F, Danev R, Pfeifer G, Nagy I, Baumeister W. Cryo-EM structures of the archaeal PAN-proteasome reveal an around-the-ring ATPase cycle. PNAS. 2019;116:534–539. doi: 10.1073/pnas.1817752116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Malik IT, Brötz-Oesterhelt H. Conformational control of the bacterial clp protease by natural product antibiotics. Natural Product Reports. 2017;34:815–831. doi: 10.1039/C6NP00125D. [DOI] [PubMed] [Google Scholar]
  58. Marr CR, Benlekbir S, Rubinstein JL. Fabrication of carbon films with ∼ 500nm holes for cryo-EM with a direct detector device. Journal of Structural Biology. 2014;185:42–47. doi: 10.1016/j.jsb.2013.11.002. [DOI] [PubMed] [Google Scholar]
  59. Martin A, Baker TA, Sauer RT. Rebuilt AAA + motors reveal operating principles for ATP-fuelled machines. Nature. 2005;437:1115–1120. doi: 10.1038/nature04031. [DOI] [PubMed] [Google Scholar]
  60. Martin A, Baker TA, Sauer RT. Distinct static and dynamic interactions control ATPase-peptidase communication in a AAA+ protease. Molecular Cell. 2007;27:41–52. doi: 10.1016/j.molcel.2007.05.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Martin A, Baker TA, Sauer RT. Diverse pore loops of the AAA+ ClpX machine mediate unassisted and adaptor-dependent recognition of ssrA-tagged substrates. Molecular Cell. 2008a;29:441–450. doi: 10.1016/j.molcel.2008.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Martin A, Baker TA, Sauer RT. Pore loops of the AAA+ ClpX machine grip substrates to drive translocation and unfolding. Nature Structural & Molecular Biology. 2008b;15:1147–1151. doi: 10.1038/nsmb.1503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Martin A, Baker TA, Sauer RT. Protein unfolding by a AAA+ protease is dependent on ATP-hydrolysis rates and substrate energy landscapes. Nature Structural & Molecular Biology. 2008c;15:139–145. doi: 10.1038/nsmb.1380. [DOI] [PubMed] [Google Scholar]
  64. Meyerson JR, Rao P, Kumar J, Chittori S, Banerjee S, Pierson J, Mayer ML, Subramaniam S. Self-assembled monolayers improve protein distribution on holey carbon cryo-EM supports. Scientific Reports. 2015;4:7084. doi: 10.1038/srep07084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Monroe N, Han H, Shen PS, Sundquist WI, Hill CP. Structural basis of protein translocation by the Vps4-Vta1 AAA ATPase. eLife. 2017;6:e24487. doi: 10.7554/eLife.24487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Nørby JG. Coupled assay of Na+,K+-ATPase activity. Methods in Enzymology. 1988;156:116–119. doi: 10.1016/0076-6879(88)56014-7. [DOI] [PubMed] [Google Scholar]
  67. Olivares AO, Baker TA, Sauer RT. Mechanistic insights into bacterial AAA+ proteases and protein-remodelling machines. Nature Reviews Microbiology. 2016;14:33–44. doi: 10.1038/nrmicro.2015.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Ortega J, Singh SK, Ishikawa T, Maurizi MR, Steven AC. Visualization of substrate binding and translocation by the ATP-dependent protease, ClpXP. Molecular Cell. 2000;6:1515–1521. doi: 10.1016/S1097-2765(00)00148-9. [DOI] [PubMed] [Google Scholar]
  69. Ortega J, Lee HS, Maurizi MR, Steven AC. Alternating translocation of protein substrates from both ends of ClpXP protease. The EMBO Journal. 2002;21:4938–4949. doi: 10.1093/emboj/cdf483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Ortega J, Lee HS, Maurizi MR, Steven AC. ClpA and ClpX ATPases bind simultaneously to opposite ends of ClpP peptidase to form active hybrid complexes. Journal of Structural Biology. 2004;146:217–226. doi: 10.1016/j.jsb.2003.11.023. [DOI] [PubMed] [Google Scholar]
  71. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF chimera--a visualization system for exploratory research and analysis. Journal of Computational Chemistry. 2004;25:1605–1612. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
  72. Pickart CM, Cohen RE. Proteasomes and their kin: proteases in the machine age. Nature Reviews Molecular Cell Biology. 2004;5:177–187. doi: 10.1038/nrm1336. [DOI] [PubMed] [Google Scholar]
  73. Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nature Methods. 2017;14:290–296. doi: 10.1038/nmeth.4169. [DOI] [PubMed] [Google Scholar]
  74. Raju RM, Goldberg AL, Rubin EJ. Bacterial proteolytic complexes as therapeutic targets. Nature Reviews Drug Discovery. 2012;11:777–789. doi: 10.1038/nrd3846. [DOI] [PubMed] [Google Scholar]
  75. Ripstein ZA, Huang R, Augustyniak R, Kay LE, Rubinstein JL. Structure of a AAA+ unfoldase in the process of unfolding substrate. eLife. 2017;6:e25754. doi: 10.7554/eLife.25754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Russo CJ, Passmore LA. Ultrastable gold substrates for electron cryomicroscopy. Science. 2014;346:1377–1380. doi: 10.1126/science.1259530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Shin M, Asmita A, Puchades C, Adjei E, Wiseman RL, Karzai AW, Lander GC. Distinct structural features of the lon protease drive conserved Hand-over-Hand substrate translocation. bioRxiv. 2019 doi: 10.1101/617159. [DOI]
  78. Siddiqui SM, Sauer RT, Baker TA. Role of the processing pore of the ClpX AAA+ ATPase in the recognition and engagement of specific protein substrates. Genes & Development. 2004;18:369–374. doi: 10.1101/gad.1170304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Singh SK, Grimaud R, Hoskins JR, Wickner S, Maurizi MR. Unfolding and internalization of proteins by the ATP-dependent proteases ClpXP and ClpAP. PNAS. 2000;97:8898–8903. doi: 10.1073/pnas.97.16.8898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Tivol WF, Briegel A, Jensen GJ. An improved cryogen for plunge freezing. Microscopy and Microanalysis. 2008;14:375–379. doi: 10.1017/S1431927608080781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Wang J, Hartling JA, Flanagan JM. The structure of ClpP at 2.3 A resolution suggests a model for ATP-dependent proteolysis. Cell. 1997;91:447–456. doi: 10.1016/S0092-8674(00)80431-6. [DOI] [PubMed] [Google Scholar]
  82. Wang RY, Kudryashev M, Li X, Egelman EH, Basler M, Cheng Y, Baker D, DiMaio F. De novo protein structure determination from near-atomic-resolution cryo-EM maps. Nature Methods. 2015;12:335–338. doi: 10.1038/nmeth.3287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Wong KS, Mabanglo MF, Seraphim TV, Mollica A, Mao YQ, Rizzolo K, Leung E, Moutaoufik MT, Hoell L, Phanse S, Goodreid J, Barbosa LRS, Ramos CHI, Babu M, Mennella V, Batey RA, Schimmer AD, Houry WA. Acyldepsipeptide analogs dysregulate human mitochondrial ClpP protease activity and cause apoptotic cell death. Cell Chemical Biology. 2018;25:1017–1030. doi: 10.1016/j.chembiol.2018.05.014. [DOI] [PubMed] [Google Scholar]
  84. Wong KS, Houry WA. Recent Advances in Targeting Human Mitochondrial AAA+ Proteases to Develop Novel Cancer Therapeutics. In: Urbani A, Babu M, editors. Mitochondria in Health and in Sickness. Singapore: Springer; 2019. pp. 119–142. [DOI] [PubMed] [Google Scholar]
  85. Yu H, Lupoli TJ, Kovach A, Meng X, Zhao G, Nathan CF, Li H. ATP hydrolysis-coupled peptide translocation mechanism of Mycobacterium tuberculosis ClpB. PNAS. 2018;115:E9560–E9569. doi: 10.1073/pnas.1810648115. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision letter

Editor: Axel T Brunger1
Reviewed by: Gabriel C Lander2

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Acceptance summary:

Bacterial ClpXP is an ATP-fueled chambered protease, akin to the 26S proteasome in eukaryotic cells. ClpXP consists of a hexameric AAA+ unfoldase (ClpX) that recognizes, unfolds, and threads SsrA-tagged substrates into the tetradecameric ClpP barrel composed of two heptameric rings, where substrates are degraded. Ripstein et al. now reports the cryo-EM structure of the ClpXP protease from Neisseria meningitidis engaged with the model substrate, GFP-SsrA. This study reveals two distinct conformations (termed A and B), at relatively high resolution. These structures are consistent with a sequential mechanism of substrate translocation, although the structures do not rule out other possibilities. Moreover, the structures suggest how a symmetry mismatch between ClpX and ClpP may contribute to the overall mechanism.

Decision letter after peer review:

Thank you for submitting your article "A processive rotary mechanism couples substrate unfolding and proteolysis in the ClpXP degradation machinery" for consideration by eLife. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and John Kuriyan as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Gabriel C Lander (Reviewer #3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Essential revisions:

1) It is mentioned that the E185Q Walker mutant was used for the structural studies to slow hydrolysis (Results paragraph one, but not mentioned in the Materials and methods). Was this mutant used for the functional studies (Figure 1) as well? In any case, how "slow" is this mutant? What fraction of the substrates will be unfolded within 10 mins, i.e., the time before flash freezing the samples?

2) All residues of substrate for both conformations (A and B) are modelled as alanine, but they do not clearly match the corresponding density maps. Please comment and discuss.

3) The lack of clear density for the sidechains of the substrate (or density of the substrate outside the ClpXP holoenzyme) for the two makes it difficult to uniquely correlate the two observed conformations of ClpXP with two different "translocation" states of the substrate. Although the model (Figure 5) is reasonable, the two structures presented in this study do not necessarily rule out other possibilities.

4) For conformation A, the resolution for the two promoters at either side of the seam is substantially lower (Figure 4—figure supplement 2) than the rest of the structure. Can one be sure that it is actually ADP bound to these protomers in conformation A? It could also be a resolution effect. Moreover, density for not only the nucleotide, but the surrounding regions should be included for all binding pockets.

5) Density for Mg2+ is mentioned, but the figure that is provided (Figure 4) shows the density at only one contour level, such that the putative Mg2+ density is merged with the density of the nucleotide. Two different contour levels should be shown. In any case, the "resolution" of the Mg2+ density does not seem to be as high as some of the sidechain densities shown and certainly not as high as estimated from the FSC. Please comment and discuss. Also, some the Mg2+ may not be properly modeled since they appear outside of density.

6) The present work represents the third cryoEM structure of the ClpXP protease and is preceded by the recent publication of Listeria monocytogenes ClpXP (Gatsogiannis et al., NSMB 2019). Contrary to the previous work, the structure by Ripstein et al. is of much higher resolution (2.3A vs ~4A), providing more accurate mechanistic insight. Perhaps most surprisingly, Gatsogiannis et al. reported the existence of unusual head-to-head ClpXP dimers that were the prevalent specimen in their cryoEM sample. Whether head-to-head dimers are artifactual or physiological is currently unclear. However, it seems appropriate to compare and comment on the previously published structures and to discern why such head-to-head dimers were not observed in the present study since full-length ClpX was also used here.

7) In the present structure, five of the six pore loops interact tightly with the substrate backbone supporting a processive substrate handover between neighboring subunits. This is somewhat unexpected as it is widely presumed that ClpX threads substrates stochastically. For instance, using a covalently linked ClpX hexamer, the Sauer and Baker groups showed that only one active ClpX subunit is sufficient for function. How can the present structures be reconciled with the wealth of biochemical and genetic data in the literature supporting a probabilistic mechanism?

8) To illuminate the structural basis for substrate engagement and threading, the authors used GFP-SsrA, which is more informative than the more commonly used casein that is natively unstructured. However, it is unclear how much of SsrA vs unfolded GFP is seen in the structure. Does GFP remain mostly folded and, if not, what is the structural/mechanical basis for GFP unfolding? The authors ought to comment on this.

9) The authors propose that the X5 subunit in conformation A contains an ATP molecule that is "primed" for hydrolysis. Lander et al. observed a similar nucleotide binding site environment in the Lon complex, and also proposed this scenario. However, this is incompatible with studies showing that an Arginine finger in trans is required for hydrolysis. The resolution of the reconstruction does not enable the authors to discern between ATP and a post-hydrolysis/long-lived ADP-Pi state that may be induced by the Walker B mutation. Unless the authors are able to posit a reasonable hydrolysis mechanism that explains how hydrolysis could occur in this chemical environment in a manner that satisfies prior observations regarding hydrolysis, this aspect of the mechanism must be reconsidered. This should include a more detailed and quantitative description of the Walker B motif becoming positioned "closer" to the ATP in this subunit.

10) The nominal resolution of the structure may enable a detailed description of the allostery involved in ClpP gate opening. It is mentioned that the rigidification is similar to that observed upon ADEP binding, but are there any differences observed or previously uncharacterized interactions? A more thorough description with associated figures should be included, as this aspect of the structure is particularly important.

11) The observed interaction between H230 within the RKH loop and substrate is intriguing and warrants further investigation. Despite all the mutagenesis that's been done on this loop, as far as I know no one has made a single point mutation at this histidine. The strength of the density between the H230 and substrate is indicative of a substantial interaction, the functional significance of which should be probed biochemically.

[Editors' note: further revisions were suggested prior to acceptance, as described below.]

Thank you for resubmitting your work entitled "A processive rotary mechanism couples substrate unfolding and proteolysis in the ClpXP degradation machinery" for further consideration by eLife. Your revised article has been evaluated favorably by John Kuriyan (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below. Please address these issues in a revised manuscript, using your best judgement. We will make a final decision on the revised manuscript at the editorial level.

Reviewer #1:

I would like to thank the authors for addressing my concerns. I have no further comments and fully support publication in eLife.

Reviewer #2:

The manuscript by Ripstein et al. is substantially improved. The new data shown in Figure 5 addresses concerns regarding the proposed sequential mechanism, and the authors' comment regarding glutaraldehyde crosslinking used by Gatsogiannis et al., 2019 is adequate, although not further substantiated. Few minor issues remain that need clarification.

1) "The RKH loops are essential for the recognition of SsrA-tagged substrates by E. coli ClpX, while human ClpX, which lacks RKH loops loops but contains pore-1 loops with the same sequence as E. coli ClpX, fails to recognize substrates with the SsrA-tag."

Human ClpX features an RKL tripeptide (residues 401-403) instead of an "RKH motif" at the same position downstream of pore-1 loop. Since human ClpX fails to recognize ssrA-tagged substrates, it would seem that H230 is the main determinant for SsrA substrate binding as pointed out by one reviewer. While there is no reason to doubt the Farrell et al., 2007 findings, the explanation that electrostatic interactions via the charged Lys confer substrate specificity does not seem warranted according to the present structure. This statement needs to be revised.

2) Abstract: "… cyclical hydrolysis of ATP is coupled to concerted motions of ClpX loops…" This statement can be misleading, especially when the Abstract is read in isolation (e.g. in Pubmed), and should be revised. The authors' concluded that ATP hydrolysis occurs sequentially, but this was not stated in the Abstract. When taken in isolation, concerted motions refer to a third model distinct from the sequential and stochastic model.

Reviewer #3:

I am generally satisfied with the revised manuscript, and the authors have addressed all the points I brought up in my initial review. However, the authors introduce a new experiment (Figure 5), whose results they interpret as evidence of a sequential hydrolysis translocation mechanism. The experiment is nearly identical to one that was published as Figure 1 Martin et al., 2008 (PMID 18223658). The observed curve for GFP degradation has been previously established, and proposed to be unrelated to processivity of translocation due to the fast refolding of destabilized GFP intermediates. Lowering the motor speed enables GFP to refold and escape degradation, and could occur whether ClpX utilizes a probabilistic or sequential ATP hydrolysis mechanism. Further, given that the conformations associated with substrate engagement and commitment are unknown, and that these processing steps could also be perturbed by introducing a single slowly hydrolyzing subunit, one cannot exclude a probabilistic mechanism.

The manuscript provides many insights into the mechanism of ClpXP substrate processing and that this work will be well-received by the AAA community, but the conclusions regarding sequential hydrolysis are unfounded. I suggest that the experiments and interpretation associated with Figure 5 be removed.

eLife. 2020 Jan 9;9:e52158. doi: 10.7554/eLife.52158.sa2

Author response


Essential revisions:

1) It is mentioned that the E185Q Walker mutant was used for the structural studies to slow hydrolysis (Results paragraph one, but not mentioned in the Materials and methods). Was this mutant used for the functional studies (Figure 1) as well? In any case, how "slow" is this mutant? What fraction of the substrates will be unfolded within 10 mins, i.e., the time before flash freezing the samples?

We apologize for the lack of clarity. The E185Q Walker B mutant was not used for the functional assays (Figure 1B). We have revised the figure caption to reflect this change:

“All measurements included GFP-SsrA and were performed in triplicate on WT ClpXP”

In a new figure, we show that the ATPase rate of the E185Q Walker B mutant of ClpX is ~17 times slower compared to the WT enzyme (Figure 5A). We believe that the substrate density in the maps corresponds to the unstructured region of the SsrA-tag of GFP that has been engaged and slowly translocated. Given the low activity, we believe the fraction of GFP that is unfolded prior to vitrification is negligible. We have clarified the text to reflect this:

“As the Walker B mutant has low unfolding activity (see below), the observed density likely corresponds to the unstructured region of the degron tag”

2) All residues of substrate for both conformations (A and B) are modelled as alanine, but they do not clearly match the corresponding density maps. Please comment and discuss.

While there is clear density for some bulkier side chains in the map, it was not possible to register the substrate peptide sequence in the density and therefore the substrate has been modeled as polyalanine. The density may correspond to the SsrA tag, although our attempts to fit that sequence into the density were unsuccessful, perhaps because the consensus structure is an average of multiple translocation steps of the SsrA sequence. We have added the following line in the Materials and methods to clarify this situation:

“While the experimental density for the substrate showed some bulky side chains, attempts to register the SsrA sequence in the density were unsuccessful and the substrate was modeled as polyalanine.”

3) The lack of clear density for the sidechains of the substrate (or density of the substrate outside the ClpXP holoenzyme) for the two makes it difficult to uniquely correlate the two observed conformations of ClpXP with two different "translocation" states of the substrate. Although the model (Figure 5) is reasonable, the two structures presented in this study do not necessarily rule out other possibilities.

We agree with the reviewers that a lack of register for the substrate chain complicates using it as a marker of translocation direction. However, in our proposed model the direction of substrate translocation is towards ClpP and is supported by both the nucleotide content of the observed states, and the pore loop positions. We have added new functional assays (Figure 5B – see reviewer comment #7) that further support this model. We do nonetheless accept that there are other possible models and have indicated as such in the text:

“The model described above is the simplest one that is consistent with our data. More complicated models can be envisioned that require additional states for which we have no experimental data.”

4) For conformation A, the resolution for the two promoters at either side of the seam is substantially lower (Figure 4—figure supplement 2) than the rest of the structure. Can one be sure that it is actually ADP bound to these protomers in conformation A? It could also be a resolution effect. Moreover, density for not only the nucleotide, but the surrounding regions should be included for all binding pockets.

While lower resolution near the seam in Conformation A makes the density for nucleotide in the binding pockets at the seam less clear, it is still sufficient to identify the nucleotide state. The ADP state of these pockets is also reinforced by the conformation of the surrounding residues. We have added a figure supplement (Figure 4—figure supplement 3) to show surrounding density as well:

“Figure 4—figure supplement 3. ATP binding pocket densities. Experimental density maps and models are shown for the ATP binding pockets of all protomers. Two numerical thresholds are shown to highlight differences in density.”

5) Density for Mg2+ is mentioned, but the figure that is provided (Figure 4) shows the density at only one contour level, such that the putative Mg2+ density is merged with the density of the nucleotide. Two different contour levels should be shown. In any case, the "resolution" of the Mg2+ density does not seem to be as high as some of the sidechain densities shown and certainly not as high as estimated from the FSC. Please comment and discuss. Also, some the Mg2+ may not be properly modeled since they appear outside of density.

We have added Figure 4—figure supplement 3 showing the two contour levels for putative Mg2+ (see reviewer comment #4). We believe that the Mg2+ density is comparable to other cryo-EM reconstructions at similar estimated resolutions. We have remodelled the Mg2+ such that it better corresponds to the observed density.

6) The present work represents the third cryoEM structure of the ClpXP protease and is preceded by the recent publication of Listeria monocytogenes ClpXP (Gatsogiannis et al., NSMB 2019). Contrary to the previous work, the structure by Ripstein et al. is of much higher resolution (2.3A vs ~4A), providing more accurate mechanistic insight. Perhaps most surprisingly, Gatsogiannis et al. reported the existence of unusual head-to-head ClpXP dimers that were the prevalent specimen in their cryoEM sample. Whether head-to-head dimers are artifactual or physiological is currently unclear. However, it seems appropriate to compare and comment on the previously published structures and to discern why such head-to-head dimers were not observed in the present study since full-length ClpX was also used here.

We did not observe any head-to-head dimers in any of our preparations. The authors of the Listeria monocytogenes ClpXPmanuscript utilized the glutaraldehyde chemical crosslinker in their sample preparation that may have affected the oligomeric state they observed. Our study did not use any crosslinking agent. We have added the following sentence to the Discussion:

“In the case of L. monocytogenes ClpXP, unusual head-to-head dimers were observed that appeared to be mediated by the zinc binding domains. Despite the presence of the zinc binding domains in our N. meningitidis construct, no such dimers were observed. While this difference may be due to differences across species, we note that the glutaraldehyde chemical crosslinker used to stabilize the L. monocytogenes ClpXP complex may have induced the formation of artefactual dimers.”

7) In the present structure, five of the six pore loops interact tightly with the substrate backbone supporting a processive substrate handover between neighboring subunits. This is somewhat unexpected as it is widely presumed that ClpX threads substrates stochastically. For instance, using a covalently linked ClpX hexamer, the Sauer and Baker groups showed that only one active ClpX subunit is sufficient for function. How can the present structures be reconciled with the wealth of biochemical and genetic data in the literature supporting a probabilistic mechanism?

In an effort to better understand the previously reported linked-hexamer data from the Sauer group in the context of our and many other substrate-bound AAA+ unfoldase structures that support a processive hand-over-hand mechanism, we performed our own mixed hexamer assays (Figure 5B). Here we mix WT and E185Q Walker B protomers of ClpX in different ratios and incubate them overnight so as to generate composite complexes with various protomer types whose exact composition and population can be calculated using combinatorial statistics. GFP-SsrA assays performed on samples described above show that the presence of a single E185Q Walker B protomer in the ClpX hexamer is enough to completely stop the degradation of GFP-SsrA by ClpXP. This further bolsters our processive model and is inconsistent with the previous stochastic model which predicts that unfolding and translocation is possible with just a single active subunit.

We would also note that in the experiments by the Sauer and Baker groups, the assumption is that the Walker B mutants are “dead”. As we show here (Figure 5A) and as reported by Sauer et. al elsewhere (Martin et al., 2008a), Walker B ClpX exhibits ~17 fold lower ATPase activity compared to the WT enzyme. As such the processivity of these mixed enzymes would be expected to be much lower than a fully WT complex. Furthermore, the substrates used in many of these experiments (e.g. Titin-SsrA, destabilized mutants of Titin-SsrA) have much lower stability compared to the tightly-folded GFP and may only require a few translocation steps to unfold. In the case of unstable or disordered substrates, translocation may take place slower compared to the WT enzyme but would register as “active”. Indeed, in our structures we show that ClpX binds GFP-SsrA (Figure 1—figure supplement 1) and believe that the substrate density in our maps corresponds to the unstructured SsrA tag of GFP which has been slowly translocated by our Walker B ClpX.

We have added the following text to the manuscript:

“The arrangement of nucleotides in our map suggests that substrate-bound ClpX hydrolyzes ATP in a sequential manner, contrary to previous reports that ATP hydrolysis by ClpX is a stochastic process (Martin et al., 2005). […] It is inconsistent with the previous stochastic model that predicts that unfolding and translocation are possible with just a single active subunit.”

And figure caption:

“Figure 5. A single defective ClpX protomer derails function. (A) ATPase rates for WT ClpX and the E185Q ClpX Walker B mutant. […] This observation contrasts the expected linear decrease (green line) for a stochastic model. (C) Schematic of the molecules produced via mixing.”

The associated Materials and methods section:

“…For the mixed protomer ClpX assays, WT ClpX and E185Q ClpX samples were purified separately as described above (i.e. without the addition of any nucleotide) and mixed at the indicated ratios. […] The wells included an ATP-regeneration system that contained 1.5 mM phosphoenolpyruvate, 0.2 mM NADH, 40 μg/mL pyruvate kinase, 40 μg/mL lactate dehydrogenase, and 2 mM MgATP at pH 8.2. Hydrolysis of ATP was monitored by loss of absorption at 340 nm with a Synergy Neo2 96-well microplate reader at 25 °C.”

8) To illuminate the structural basis for substrate engagement and threading, the authors used GFP-SsrA, which is more informative than the more commonly used casein that is natively unstructured. However, it is unclear how much of SsrA vs unfolded GFP is seen in the structure. Does GFP remain mostly folded and, if not, what is the structural/mechanical basis for GFP unfolding? The authors ought to comment on this.

Based on activity assays done with the E185Q Walker B mutant (see new Figure 5) we believe that GFP remains folded and the portion we observe in the structure corresponds to the C-terminal SsrA tag, which is natively unstructured and has begun to be translocated. We have clarified the text to reflect this.

“As the Walker B mutant has low unfolding activity, the density observed likely corresponds to the unstructured region of the degron tag.”

9) The authors propose that the X5 subunit in conformation A contains an ATP molecule that is "primed" for hydrolysis. Lander et al. observed a similar nucleotide binding site environment in the Lon complex, and also proposed this scenario. However, this is incompatible with studies showing that an Arginine finger in trans is required for hydrolysis. The resolution of the reconstruction does not enable the authors to discern between ATP and a post-hydrolysis/long-lived ADP-Pi state that may be induced by the Walker B mutation. Unless the authors are able to posit a reasonable hydrolysis mechanism that explains how hydrolysis could occur in this chemical environment in a manner that satisfies prior observations regarding hydrolysis, this aspect of the mechanism must be reconsidered. This should include a more detailed and quantitative description of the Walker B motif becoming positioned "closer" to the ATP in this subunit.

We agree with the reviewers on this point. It is entirely possible that the conformation we observed in this study is a stabilized post-hydrolysis state or indeed a mixture of pre- and post-hydrolysis states. While it is interesting that the sensor-2 arginine adopts a conformation similar to that of the canonical arginine finger, our maps are not at a sufficient resolution to adequately interpret a new mechanism and as such we have carefully reworded the text to remove mention of this site as being primed for hydrolysis and simply note that it is different from the other observed sites and may represent a post-hydrolysis/long-lived ADP-Pi state. We have clarified the text to reflect this:

“In the X5 protomer (at the bottom of the spiral), the adjacent X6 protomer and its arginine finger have pivoted away from the nucleotide into the LS position, allowing the sensor-II arginine to move closer to the γ-phosphate of the bound nucleotide. While there is clear density for the γ-phosphate, the resolution of our experimental map was not sufficient to differentiate between ATP and a long-lived post hydrolysis ADP/Pi state. Notably, this key sensor II-priming motif in the nucleotide site adjacent to an ADP bound site has also been reported for the Lon protease bound to substrate (Shin et al., 2019), a close relative in the HCLR clade of AAA+ proteins.”

10) The nominal resolution of the structure may enable a detailed description of the allostery involved in ClpP gate opening. It is mentioned that the rigidification is similar to that observed upon ADEP binding, but are there any differences observed or previously uncharacterized interactions? A more thorough description with associated figures should be included, as this aspect of the structure is particularly important.

We agree with the reviewers that this aspect of the structure is of particular interest. There are differences to the gate opening observed with ADEP compared with our ClpXP structures. Most notably not all gates assume the “up” conformation equally (Figure 2) and the offset of ClpX relative to ClpP creates new asymmetric interactions with the N-terminal gates. Further insights into the allosteric mechanism, particularly communication between ClpP protomers did not seem to differ from that of the high resolution ADEP structures. We believe Figure 2E and G and Figure 2—figure supplement 2 and the associated text of our original submission addressed this important point.

11) The observed interaction between H230 within the RKH loop and substrate is intriguing and warrants further investigation. Despite all the mutagenesis that's been done on this loop, as far as I know no one has made a single point mutation at this histidine. The strength of the density between the H230 and substrate is indicative of a substantial interaction, the functional significance of which should be probed biochemically.

We agree with the reviewers that the interaction of H230 and the substrate is intriguing, and that our models suggest it plays an important role in substrate processing. However, we do not think further mutagenesis work is warranted because RKH loop mutants have been extensively probed by the Sauer lab in the past (Farrell et al., 2007; Martin et al., 2008b) as well as in a recent preprint (Fei et al., 2019), including the single point mutation of the RKH histidine. These publications clearly show that mutating the RKH loop to AAA abrogates degradation of SsrA-tagged substrates, and furthermore that a simple swapping of the Lys and His positions (RKH to RHK) also results in a severe reduction of degradation of SsrA-tagged substrates. Additionally the single point mutation of the histidine to alanine (RKA) resulted in loss of degradation for both SsrA and λO tagged substrates (Farrell et al., 2007). The specific positioning of a single H230 in our structure may provide an explanation for the sensitivity of activity to changes in this loop. We have added the following text and citations to discuss this point:

“The differences in these interactions may reflect the fact that while pore-1 loop and RKH loop motifs are critical for forming interactions with substrate, and in the case of pore-1 loops in particular, in providing the force for translocation, additional contacts may differ between species and may be necessary for recognition of degradation signals and for substrate specificity. […] The tight contact between H230 and the substrate in our maps provides a structural basis for understanding these mutagenesis results.”

[Editors' note: further revisions were suggested prior to acceptance, as described below.]

Reviewer #2:

The manuscript by Ripstein et al. is substantially improved. The new data shown in Figure 5 addresses concerns regarding the proposed sequential mechanism, and the authors' comment regarding glutaraldehyde crosslinking used by Gatsogiannis et al., 2019 is adequate, although not further substantiated. Few minor issues remain that need clarification.

1) "The RKH loops are essential for the recognition of SsrA-tagged substrates by E. coli ClpX, while human ClpX, which lacks RKH loops loops but contains pore-1 loops with the same sequence as E. coli ClpX, fails to recognize substrates with the SsrA-tag."

Human ClpX features an RKL tripeptide (residues 401-403) instead of an "RKH motif" at the same position downstream of pore-1 loop. Since human ClpX fails to recognize ssrA-tagged substrates, it would seem that H230 is the main determinant for SsrA substrate binding as pointed out by one reviewer. While there is no reason to doubt the Farrell et al., 2007 findings, the explanation that electrostatic interactions via the charged Lys confer substrate specificity does not seem warranted according to the present structure. This statement needs to be revised.

We thank the reviewer for brinting this point to our attention. We have removed the text corresponding to the electrostatics explanation and now mention the mitchondrial ClpX RKL tripeptide:

“The RKH loops are essential for the recognition of SsrA-tagged substrates by E. coli ClpX, while human ClpX, which substitutes the RKH sequence with an RKL tripeptide and contains pore-1 loops with the same sequence as E. coli ClpX, fails to recognize substrates with the SsrA-tag..”

2) Abstract: "… cyclical hydrolysis of ATP is coupled to concerted motions of ClpX loops…" This statement can be misleading, especially when the Abstract is read in isolation (e.g. in Pubmed), and should be revised. The authors' concluded that ATP hydrolysis occurs sequentially, but this was not stated in the Abstract. When taken in isolation, concerted motions refer to a third model distinct from the sequential and stochastic model.

The text has been modified as follows to address this ambiguity:

“The structures allow development of a model in which the sequential hydrolysis of ATP is coupled to motions of ClpX loops that lead to directional substrate translocation and ClpX rotation relative to ClpP.”

Reviewer #3:

I am generally satisfied with the revised manuscript, and the authors have addressed all the points I brought up in my initial review. However, the authors introduce a new experiment (Figure 5), whose results they interpret as evidence of a sequential hydrolysis translocation mechanism. The experiment is nearly identical to one that was published as Figure 1 Martin et al., 2008 (PMID 18223658). The observed curve for GFP degradation has been previously established, and proposed to be unrelated to processivity of translocation due to the fast refolding of destabilized GFP intermediates. Lowering the motor speed enables GFP to refold and escape degradation, and could occur whether ClpX utilizes a probabilistic or sequential ATP hydrolysis mechanism. Further, given that the conformations associated with substrate engagement and commitment are unknown, and that these processing steps could also be perturbed by introducing a single slowly hydrolyzing subunit, one cannot exclude a probabilistic mechanism.

The manuscript provides many insights into the mechanism of ClpXP substrate processing and that this work will be well-received by the AAA community, but the conclusions regarding sequential hydrolysis are unfounded. I suggest that the experiments and interpretation associated with Figure 5 be removed.

We thank this reviewer for his/her comments. The sequential vs. stochastic discussion is certainly controversial and merits a more detailed investigation. As per this reviewers’ suggestion, we have removed Figure 5 and all the associated text. We have added the following to the Discussion:

“The model described above is the simplest one that is consistent with our data. While our structures suggest that a sequential hydrolysis model exists for ClpXP, more complicated models can be envisioned that require additional states for which we have no experimental data. Indeed biochemical evidence suggests the possibility that when one or more subunits are catalytically deficient a more complex mechanism may be operational, allowing ClpXP to deviate from a strictly sequential hydrolysis scheme (Martin et al., 2008b).”

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation A. RCSB Protein Data Bank. 6VFS
    2. Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation B. RCSB Protein Data Bank. 6VFX
    3. Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation A. Electron Microscopy Data Bank. EMD-21187
    4. Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation B. Electron Microscopy Data Bank. EMD-21194
    5. Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP D7. Electron Microscopy Data Bank. EMD-21195
    6. Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps Apo-NmClpP. Electron Microscopy Data Bank. EMD-21196

    Supplementary Materials

    Transparent reporting form

    Data Availability Statement

    CryoEM maps and models have been deposited in the EMDB and PDB.

    The following datasets were generated:

    Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation A. RCSB Protein Data Bank. 6VFS

    Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation B. RCSB Protein Data Bank. 6VFX

    Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation A. Electron Microscopy Data Bank. EMD-21187

    Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP Conformation B. Electron Microscopy Data Bank. EMD-21194

    Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps NmClpXP D7. Electron Microscopy Data Bank. EMD-21195

    Ripstein ZA, Vahidi S, Houry WA, Rubinstein JL, Kay LE. 2020. Maps Apo-NmClpP. Electron Microscopy Data Bank. EMD-21196


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES